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ABSTRACT 
 
Objectives:  Haematopoetic Stem Cell Transplant (HSCT) is a potentially curative 
treatment for haematological cancers and related disorders.  However the treatment is 
extremely aggressive and potentially life threatening.   HSCT impacts all aspects of 
recipients‟ lives due to its associated physical and psychosocial sequelae.  Recipients 
of HSCT represent a unique group of individuals with cancer and interventions to 
maintain  or  improve  quality  of  life  and  wellbeing  has  been  limited.    To  date, 
interventions have mainly focused on the impact of exercise interventions, however, 
psychosocial  interventions  are  increasingly  being  utilised  with  this  population.  
Psychosocial interventions have demonstrated effectiveness among other groups of 
individuals  with  cancer.    However,  little  is  known  regarding  the  impact  of  such 
interventions with HSCT recipients.  This present review therefore aims to identify 
psychosocial intervention studies within this population and summarise the findings 
regarding the impact upon quality of life and psychosocial outcomes.     
Methods:    A  systematic  search  was  performed  using  Ovid;  Medline &  Embase, 
EBSCO; CINHAL, PsychINFO & SocINDEX and Cochrane Library databases to 
identify  relevant  studies.    Eight  studies  were  identified  as  meeting 
inclusion/exclusion  criteria.    Methodological  quality  of  the  eight  studies  was 
determined by using a specifically adapted checklist.    
Results:  Four studies were rated “good”; one study was rated as “moderate”; and 
three  as  being  of  “poor”  methodological  quality.    The  findings  indicated  that 
psychosocial interventions are highly heterogeneous making it difficult to compare 
findings.  Emotional functioning is the most frequently investigated outcome to date 
and  positive  findings  were  identified  in  all  eight  studies  for  at  least  one  QOL 
outcome parameter.        
Conclusions:    To  date,  there  is  insufficient  evidence  to  suggest  conclusive 
effectiveness  of  psychosocial  interventions  as  improving  QOL  among  HSCT 
recipients.  However the positive effects identified in the studies suggest that there is 
a need to conduct more methodologically sound studies.  
Keywords:    haematopoietic  stem  cell  transplant,  psychosocial  interventions, 
outcome, quality of life, systematic review.    
 
 8 
 
INTRODUCTION 
 
Haematopoietic stem cell transplantation (HSCT) is a potentially curative treatment 
for haematological cancers.  For patients receiving autologous HSCT, stem cells are 
harvested from the patients themselves whereas in allogeneic HSCT, stem cells are 
harvested from a related or unrelated donor.  Prior to receiving the transplant, many 
patients receive high-dose chemotherapy and possibly total body irradiation, leaving 
their immune system at its lowest point.  The aggressive nature of HSCT means that 
patients spend significant periods of time in hospital, often in isolation, to protect 
against  infection.    As  a  result,  normal  life  is  put  on  hold  during  treatment  and 
recovery.  Although medical advances in HSCT procedures have improved resulting 
in the control of life-threatening diseases, about 40% of advanced cancer patients 
who  undergo  allogeneic  HSCT  die  from  transplant  related  complications.
1    This 
understandably results in fear and anxiety around the uncertainty of the procedure 
and its longer term recovery implications.       
 
Regardless of transplant type, considerable physical, psychological and psychosocial 
distress  before,  during  and  after  transplant  is  experienced  by  a  majority  of 
recipients.
2,3  A variety of such difficulties have been identified in empirical research 
as being; fatigue, loss of physical fitness as well as a number of unpleasant side 
effects including nausea and pain;
4 psychological distress such as PTSD;
5 persistent 
anxiety  and  depressive  symptoms  in  a  significant  proportion.
2,6  Furthermore,   
recipients  often  experience  some  interruption  in  normal  developmental  tasks,  for 
example,  maintaining  a  career  and  establishing  satisfactory  marital  and  family 
relationships.
7,8  Distress and functioning in these areas tend to improve over time, 
however,  long  term  impairment  relative  to  non-cancer  comparison  groups  is  the 
norm.
9  Such  associated  morbidity  has  massive  potential  to  threaten  the  overall 
quality of life and wellbeing of HSCT recipients and as a result of the overwhelming 
demands made on HSCT patients, it is recognised that recipients‟ ability to utilise 
normal coping strategies is compromised, particularly in the early stages of treatment 
and recovery.    
   
Given the significant impact that HSCT can have on all aspects of lives of recipients 
and their families, research investigating interventions to improve QOL for HSCT 9 
 
recipients has increased.  To date, the predominant focus of such interventions has 
been on the effects of exercise therapy.  Recent reviews have found that exercise 
interventions in this field are still in their infancy and as such methodological quality 
is highly variable, with very few randomised controlled trials.
4,10  However, these 
reviews  concluded  that,  methodological  weaknesses  notwithstanding,  encouraging 
results were obtained for a diverse set of outcomes, such as physical fitness, health 
related  QOL  and  psychological  wellbeing,  and  recommendations  were  made  for 
future studies on the effectiveness of exercise therapy for HSCT recipients.   
 
As with exercise interventions, psychosocial interventions to improve the QOL and 
psychosocial functioning of HSCT recipients are also becoming more widespread.  
Psychosocial  interventions  use  a  variety  of  approaches  such  as  behavioural  and 
cognitive  techniques,  amongst  others,  and  aim  to  relieve  emotional  distress  and 
promote  wellbeing  and  therefore  seem  well  suited  to  use  with  HSCT  recipients.  
Although  psychosocial  interventions  with  HSCT  recipients  are  in  their  infancy, 
research  has  shown  that  such  approaches  are  effective  in  improving  wellbeing 
amongst  other  cancer  populations.    For  example,  a  meta  analysis  of  relaxation 
training among non-surgical cancer treatment patients, in reducing treatment related 
symptoms  and  improving  emotional  adjustment,  found  a  significant  effect  on 
depression (medium effect  size),  anxiety and hostility  (both small effect  sizes).
11  
This review did not focus on HSCT recipients but the findings were reported to 
suggest equal effectiveness in patients undergoing a variety of treatments, including 
HSCT.  In addition, a systematic review of mindfulness approaches suggests such 
interventions  may  have  a  place  in  cancer  care  across  the  disease  trajectory.
12  
Furthermore,  a  meta  analysis  of  the  effectiveness  of  behavioural  techniques  on 
psychosocial  functioning  and  health  related  QOL  in  breast  cancer  patients  and 
survivors  concluded  effectiveness  in  improving  fatigue,  depression,  anxiety  and 
stress in this population.
13  Effect sizes were calculated using Cohen‟s rule of thumb 
and demonstrated smaller effect sizes for fatigue (ES -0.158) and stress (ES -0.159) 
as compared to depression (ES -0.336) and anxiety (ES -0.346) although all still fall 
within the small effect size range.        
 
The  effectiveness  of  psychosocial  interventions  with  HSCT  recipients,  for  whom 
treatment has a unique impact on QOL, is yet to be established.  However, the value 10 
 
of  conducting  systematic  reviews  regarding  the  effectiveness  of  psychosocial 
interventions  for  individuals  with  cancer  is  demonstrated  by  Jacobson  &  Jim,
14 
whose  findings  about  the  management  of  anxiety  and  depression  facilitated  the 
development  of  evidence  based  recommendations  on  a  variety  of  psychosocial 
interventions for use with patients with cancer at different stages and undergoing 
different  types  of  treatments  (p.221).    This  type  of  information  is  invaluable  to 
patients and clinicians.   
           
Furthermore,  Hoodin  &  Weber
15  conducted  a  systematic  review  of  psychosocial 
factors  affecting  survival  after  HSCT.    The  reviewers‟  analysis  of  the 
methodologically sound studies suggested longer survival may be related to lower 
“anxious preoccupation”, “higher fighting spirit” and better QOL ratings before and 
soon  after  transplant  in  adults  (P.  181).    This  is  important  because  effective 
psychosocial  interventions  can  be  used  to  address  these  factors  and  potentially 
facilitate not only improved wellbeing but also survival.    
 
As far as the author of the present review is aware, no systematic reviews have been 
conducted regarding the evidence base for psychosocial interventions with HSCT 
recipients  who  face  huge  physical  and  psychosocial  demands  threatening  their 
overall  quality  of  life.    Interventions  within  the  HSCT  population  represent  a 
developing area of research therefore it is important and timely to investigate the 
state of the literature and build our understanding of the most and least effective 
approaches since “psychosocial care that is ineffective may be worse than no care at 
all” (Jacobson & Jim, p. 214).
14  
 
Therefore, the objective of the following systematic review is: 
To summarise the primary research findings obtained in psychosocial interventions 
aimed  at  improving  quality  of  life  or  psychosocial  wellbeing  in  HSCT  patients, 
taking into account the methodological quality of the studies retrieved.    
It will aim to answer the following question:  
  How  do  psychosocial  based  interventions  impact  upon  psychosocial  and 
quality of life outcome following HSCT?     
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METHOD 
 
Search strategy 
The  following  electronic  databases  were  used  to  identify  suitable  studies:  Ovid; 
Medline & Embase, EBSCO; CINHAL, PsychINFO &  SocINDEX and Cochrane 
Library. 
These  were  searched  using  the  following  search  terms  including  the  Boolean 
operator “AND”: 
 
[bone marrow transplant or hematopoietic stem cell transplant or peripheral blood 
stem cell transplant] 
 
AND 
 
[quality of life or psychosocial function or anxiety or depression] 
 
AND 
 
[outcome] 
 
AND 
 
[relaxation or psychoeducation or mindful or CBT or behavioural or psychosocial or 
art or cognitive or exercise] 
 
AND 
 
[therapy or intervention] 
 
AND 
 
[adult]  
 12 
 
A multi database search was conducted using the above search terms, in addition the 
last 5 years (2006-2011) of the following journals were hand searched: Bone Marrow 
Transplantation,  Psycho-Oncology  and  Journal  of  Psychosocial  Oncology.    The 
references  of the most  recent  reviews/editorials/commentaries, n= 5  (Liu  et  al.,
10 
Shennan  et  al.,
12  Schulz,
16  Somerfield  &  Rizzo
17,  Wiskeman  &  Huber
18)  were 
examined to ensure that no appropriate studies had been missed. 
 
Inclusion/exclusion criteria: 
All papers retrieved by the database and journal searches were examined using the 
following inclusion criteria.  Those not meeting the criteria below were excluded 
from the review. 
  Published in peer reviewed journal  
  Study examined data from original research 
  Study is written in English 
  Study uses quantitative methods and analysis 
  Participants are adults, 18 years and over 
  Participants have received or are undergoing a bone marrow transplant as 
defined by haematopoietic stem cell or peripheral blood stem cell transplant. 
  Outcome measures include psychosocial or quality of life  (e.g. depression, 
anxiety, quality of life dimensions) 
  Established or standardised assessment measures are used 
  Psycho-social  intervention  based  study  e.g.  behavioural,  cognitive 
behavioural, mindfulness, relaxation, art/music therapy etc. 
 
Given the recent up to date reviews of the effectiveness of exercise interventions on 
improving QOL and psychosocial functioning, for the purpose of the current review, 
it was decided to exclude studies utilising a sole exercise intervention.    
 
No restrictions were made regarding group size and the use of a control group.  This 
was done to maximise the number of eligible studies.   
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Data extraction and quality rating: 
 
Studies meeting the inclusion criteria were rated by the author using a quality rating 
form  adapted  from  guidance  outlined  by  the  Scottish  Intercollegiate  Guidelines 
Network  (SIGN  50  –  Annex  C)
19  and  the  Critical  Appraisal  Skills  Programme 
(CASP)
20 (See Appendix 1.2).  Studies were rated on 16 items in 4 main areas which 
were 1) Rationale 2) Participants 3) Confounding Factors and 4) Statistical Analysis 
yielding a possible total score of 25.  Each paper‟s total score was converted into a 
percentage to define a quality rating description of „Good‟ (>75%); „Moderate‟ (50-
74%); or „Poor‟ (<50%).   
 
An independent rater used the same quality rating scale to independently rate 50% 
percentage of studies randomly selected.  Disagreement between raters was resolved 
by discussion.  Table 1 (p.32) details the quality rating calculated for each study. 
 
INSERT TABLE 1 HERE 
 
RESULTS 
 
The database and key journal search identified 148 papers.  It was found that 112 
papers  were  inappropriate  to  the  current  review,  excluded  on  basis  of  title  or 
duplicates.  Abstracts and full text of the remaining 36 papers were examined using 
the full inclusion criteria, resulting in the further exclusion of a further 28 papers 
(Appendix  1.3).    The  final  number  of  studies  that  were  found  to  fully  meet  the 
inclusion criteria was 8.  These were included in the review below (Bauer-Wu et 
al.,
21 Cassileth et al.,
22 DuHamel et al.,
23 Gaston-Johansson et al.,
24 Horton-Deutsch 
et al.,
25 Jarden et al.,
26 Kim & Kim
27, and Lounsberry et al.
28).  The aforementioned 
search strategy is outlined in a flow diagram (See Figure 1; p.33).  
 
INSERT FIGURE 1 HERE 
 
It was envisaged that studies would be too heterogeneous to be combined using a 
formal meta-analysis.  Therefore, a narrative synthesis was performed.  The results 14 
 
are summarised according to the type of intervention used and outcome measures 
assessed.   
 
Description of included studies 
 
Characteristics of the included studies are shown in summary Table 2 (pp34-44).  
Five  studies  used  a  randomisation  procedure  to  allocate  the  psychosocial 
intervention.
22-24,26,27  The remaining 3 studies were uncontrolled pilot studies.   
 
INSERT TABLE 2 
 
Five studies were carried out in the United States of America.
21-25 The remaining 
three studies were carried out in Denmark
26, South Korea
27, and Canada.
28 
 
Sample characteristics 
 
The 8 intervention studies were carried out on a total number of 365 participants 
aged between 18 – 74 years, with a treatment sample size ranging 13 to 110. Where 
reported,  the  haematological  conditions  were  the  following;  Hodgkin  &  non-
Hodgkin  lymphoma,  myeloma/amyloidosis,  acute  &  chronic  myeloid  leukaemia, 
severe  aplastic  anemia,  acute  &  chronic  lymphocytic  leukaemia,  myelodysplastic 
syndrome,  and  myeloproliferative.    Only  one  study  reported  using  a  non-
haematological disease sample of breast cancer patients.
24  In terms of transplant 
type, 2 studies used solely autologous samples; n=110
24 and n=62
22.  Three used 
solely allogeneic samples; n=13,
28 n=35
27 and n=34.
26  The remaining three studies 
used  samples  comprised  of  both  allogeneic  and  autologous  recipients;  Horton-
Deutsch  et  al.
25  (n=15)  and  Bauer-Wu  et  al.
21  (n=15)  neither  of  which  reported 
frequencies.    DuHamel  et  al.
23  reported  40  autologous,  35  allogenenic,  and  6 
“missing” transplant types. 
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Description of Psychosocial Interventions  
 
A variety of interventions were utilised to measure the effect on quality of life and 
psychosocial  functioning  following  HSCT.  To  summarise,  two  studies  used 
mindfulness based approaches,
21,25 one study applied music therapy
22 and one study 
used a single Cognitive Behaviour Therapy (CBT) approach.
23 
 
Four  studies  evaluated  a  multi-modal  approach
24,26-28  that  included  at  least  two 
different types of psychosocial interventions such as breathing/relaxation techniques, 
psychoeducation  or  CBT  approach.  Moreover,  two  of  these  studies  evaluated  a 
psychosocial intervention in combination with a physical exercise programme.
26,27   
 
Setting 
 
Six  interventions  were  conducted  during  hospitalisation.
21,22,24-27  Only  1  study 
reported the length of stay in hospital which was 21 days.
22  One psycho-educational 
support  intervention  used  an  outpatient  community  based  video-conferencing 
approach for participants 0-3 years post transplant
28 and the remaining study utilised 
individual telephone cognitive-behavioural therapy sessions, also with outpatients 1-
3 years post HSCT.
23   
 
Format of interventions 
 
Six interventions were conducted with participants on an individual basis except for 
2 group based studies.
27,28  All interventions were delivered by professionals trained 
in the specific intervention.  7 interventions were standardised and/or manualised 
with the exception of the music intervention
22 which was tailor-made to the needs 
and preferences of the patients. 
 
Length of treatment 
 
The length of treatment time varied across studies, with 3 interventions delivering 
programmes up to 6 weeks.
26-28  The music therapy
22 and Comprehensive Coping 
Strategy Program
24 studies were the shortest interventions at 5-15 days; and 11 days 16 
 
respectively. Mindfulness based interventions were carried out by Horton-Deutsch et 
al.
24 for 4 weeks and by Bauer-Wu et al.
21 for 9 weeks.  The longest intervention 
study was delivered between 10-16 weeks.
23 
 
Outcome measures 
 
Outcome  measures  to  investigate  the  effects  of  the  interventions  were  all 
questionnaire  based  except  in  one  study,
23  which  additionally  used  a  structured 
diagnostic interview based on DSM-IV criteria for PTSD.   
Outcome  measures  were  highly  heterogeneous  across  QOL  and  psychosocial 
domains.  Emotional distress was measured across all eight studies.  Measurement 
was  highly  heterogeneous  with  eight  different  measures  of  emotional  distress 
reported across the studies.  The Hospital and Anxiety Depression Scale
29 was most 
frequently used, by three studies.
21,25-26  The State-Trait Anxiety Inventory
30 and The 
Beck Depression Inventory
31 were the next most frequently used, by two studies.
24,27  
The Profile of Mood States
32 was used in order to assess the effect of music therapy 
on mood.
22  One study
23 used 2 measures of emotional functioning which were The 
PTSD  Checklist  Civilian  Version
33,34  and  The  Brief  Symptom  Inventory,
35  in 
addition to the Clinician – Administered PTSD Scale for DSM-IV.
36 The Positive 
and Negative Affect Scale
37 was used in one study,
25 and finally one study
28 used the 
Impact of Event Scale – Revised.
38  
 
Physical  functioning  was  measured  across  four  studies.
21,24-26  The  Symptom 
Experience  Scale
39  was  used  by  two  studies
21,25  to  measure  physical  symptom 
frequency, intensity and distress.  One study
26 measured fatigue using The Functional 
Assessment of Cancer Therapy – Anemia scale.
40  Finally, one study
24 assessed pain 
using The Gaston-Johansson Painometer
41 as well as nausea and fatigue, using The 
Visual Analogue Scale.
42   
 
Only  two  studies  measured  overall  QOL
26,28  using  2  different  global  measures 
(Functional Assessment of Cancer Therapy – Bone Marrow Transplant;
43 and The 
European  Organization  for  Research  and  Treatment  Cancer  Quality  of  Life 
Questionnaire,
44 respectively).  In addition, Lounsberry et al.
28 measured the impact 17 
 
of  the  psychoeducational  support  group  intervention  on  2  further,  more  specific 
dimensions  of  QOL;  participants‟  spiritual  wellbeing,  using  The  Functional 
Assessment of Chronic Illness Therapy – Spiritual Wellbeing
45 and also participants‟ 
perception  of  personal  benefits  that  occur  as  a  result  of  attempts  to  cope  with 
treatment, using The Post-Traumatic Growth Inventory.
46   
 
Methodological quality of included studies  
 
The rating tool identified that 4 of the  randomised controlled trial design (RCT) 
studies  were  rated  as  good
22,23,27,27,  one  RCT  was  rated  as  moderate
24  and  the 
remaining 3 (uncontrolled studies) were of weakest  quality.
21,25,28  Scores  ranged 
between 28% - 96%. 
 
In  the  five  RCTs,  randomisation  procedure  was  clearly  described  in  all  but  one 
study,
24 which failed to report type of randomisation design and procedure utilised.  
Treatment  allocation  was  adequately  concealed  to  the  researchers  in  two  RCT 
studies.
22-23  The interventions in the remaining three RCT studies were delivered by 
the researchers thus preventing concealment.  As with most psychosocial studies it 
was not possible to blind participants to the intervention in all eight studies.   
 
In  terms  of  baseline  similarity  in  the  RCT  studies,  two  multimodal  RCTs
26,27 
explicitly reported conducting preliminary statistics (independent samples t-test of 
variance for continuous variables and Fisher‟s Exact test for categorical variables) to 
demonstrate no significant differences and showed similarity of groups at baseline 
with regard to the most important prognostic factors.  One RCT investigating the 
impact of music therapy on mood reported groups as similar at baseline with regard 
to age and length of stay in hospital, however, no preliminary statistics were reported 
as being conducted.
22  One RCT
24 reported that groups were not similar at baseline, 
that is, patients in the intervention group using a Comprehensive Coping Strategy 
Program,  found  that  40%  of  the  intervention  group  had  used  previous  coping 
compared  to  21%  of  the  control  group,  representing  a  statistically  significant 
difference in an important baseline factor.  Finally, DuHamel et al
23. did not report 
assessing baseline similarity and instead conducted later statistical analyses on the 
influence of demographic and medical factors.   18 
 
All eight studies gave a clear and detailed description of the intervention.  For RCT 
studies, four reported that the control groups received treatment as usual or standard 
care,  apart  from  the  outpatient  based  CBT  intervention
23,  whose  control  group 
received assessment only.   
 
Seven of the eight studies utilised a standardised protocol intervention, apart from the 
music therapy intervention
22 which was delivered to meet the needs and preferences 
of the patients, ensuring the interventions were delivered as intended.  Measurement 
of participant compliance, however, was reported as being an issue in two studies; In 
Gaston-Johansson et al.‟s
24 Comprehensive Coping Strategy Program, participants 
were given a diary to record use of the taught techniques, however, it is not clear 
within the study whether or not participants made use of this diary and therefore the 
extent  to  which  they  utilised  the  techniques.    In  addition,  a  mindfulness  based 
intervention, Bauer-Wu et al.
21 reported that participants did not reliably maintain 
listening logs of the mindfulness CD so the full extent of the intervention could not 
be determined.   
 
Facilitator adherence was described in four studies.
21,23,25,26  Two of these studies 
utilised a „monitoring logbook‟,
25,26 and two described receiving supervision from 
experienced clinicians or peers.
21,23  In the remaining studies, it was less clear how 
adherence and consistency to approach was monitored.         
 
The  withdrawal/dropout  of  participants  was  clearly  described  in  only  four 
studies.
21,23,26,27  Two  RCTs  described  number  and  reasons  for  dropout  for  both 
intervention  and  control  group
23,26  whereas  one  RCT,
27  reported  the  number  and 
reasons for dropout in terms of the total sample.  The uncontrolled study
21 clearly 
reported reasons for loss of 5 participants.  These aforementioned studies reported 
that, in the majority of cases, the main reasons for withdrawal/dropout were as a 
result of patients being too ill or as having died during intervention.  The remaining 
studies failed to report clearly reasons for attrition
22,25,28 and one study reported no 
attrition.
24   
 
A  variety  of  statistical  analyses  were  conducted  across  studies  (e.g.  ANOVA, 
MANOVA, ANCOVA) and there was variability in the level and detail of reported 19 
 
statistical methods and findings in the results sections.  All studies reported using a 
P-value of 0.05 as the limit of statistical significance apart from one study.
25  This 
study  reported  using  paired  t-tests  but  failed  to  report  any  statistical  results  and 
commented on the findings without statistical values alongside.  In terms of the RCT 
studies  that  did  not  fully  and/or  clearly  report  analysing  baseline  data  for 
similarity,
22,23  they  accounted  for  covariance  in  their  data  analyses.    In  the 
Comprehensive Coping Strategy Program by Gaston-Johansson et al.
24, which found 
statistically  significant  difference  in  the  baseline  factor  of  use  of  prior  coping 
methods,  they  also  reported  controlling  for  covariates  in  their  analyses.    Four 
RCTs
22,24,26,27 reported that they based their sample size on power calculations, three 
of which resulted in final sample sizes being slightly underpowered.
22,26,27  DuHamel 
et al.
23 was the only RCT not to explicitly mention utilisation of power calculation.  
Only  one  study  reported  effect  sizes  following  non-parametrical  analyses  on  a 
sample  size  of  13  participants
28  and  none  of  the  studies  calculated  clinically 
significant  change  (Jacobson  &  Truax
47).    Four  studies  included  a  follow-up 
period
21,23,25,26 ranging from 30 days to 12 months.      
  
Three  RCT  studies
22,23,26  explicitly  stated  that  intention-to-treat  analyses  were 
conducted to deal with patients who were lost to follow-up.  One RCT
27 study did 
not report using intention-to-treat framework therefore data from 7 participants lost 
to follow-up before completing the post-test were not in the final analyses.    Finally, 
one RCT
24 study reported 100% retention of participants to follow-up, therefore not 
requiring consideration of intention-to-treat.  The three uncontrolled studies
21,25,28 did 
not report using intention-to-treat analyses.  
 
The five RCT studies were evaluated against a treatment as usual control group and 
therefore  no  comparisons  can  be  made  against  other  psychosocial  interventions. 
Therefore the eight studies will be critically examined on the basis of their impact on 
quality of life, anxiety, depression and psychosocial functioning separately. 
 
 
 
 
 20 
 
Effects on QOL and Psychosocial Functioning 
 
Outcomes of studies aimed at improving one of the dimensions of patients‟ QOL or 
psychosocial functioning are summarised in Table 2 (pp34-44). 
 
Emotional functioning – distress 
 
Anxiety and depression as measures of emotional functioning were used in all eight 
studies.    Statistically  significant  positive  findings  were  reported  in  five  of  the 
included studies in terms of an emotional functioning variable; one study, utilising a 
relaxation breathing exercise
27 showed a statistically significant treatment effect for 
anxiety.    In  terms  of  depression,  Kim  and  Kim
27  also  showed  a  statistically 
significant  treatment  effect  for  depression.    One  other  study,
23  using  telephone-
administered  CBT,  demonstrated  a  statistically  significant  difference  in  terms  of 
fewer  depressive  symptoms  in  favour  of  the  intervention  group  and  results  were 
consistent across three follow-up assessments.  This study also found statistically 
significant improvements in PTSD symptoms of intrusive thoughts and avoidance as 
well as for global distress.  One study using a mindfulness approach
21 demonstrated 
statistically significant improvement over time in combined anxiety and depression 
symptoms.  The only other mindfulness study
25 reported statistically significantly 
lower  scores  in  negative  affect  after  intervention,  however,  the  authors  failed  to 
report any statistical values.  The authors of this same mindful study also reported 
anxiety  and  depression  scores  to  have  reduced  post-intervention,  however,  these 
findings  did  not  reach  statistical  significance.    Finally,  patients‟  total  mood 
disturbance scores lowered significantly following a music therapy intervention
22. 
   
In  a  multimodal  study
26  using  exercise,  relaxation  and  psychoeducation,  no 
significant  differences  were found between the intervention and control  group in 
terms of anxiety or depression.  However, notably, depression and anxiety scores 
were within the normal range for both groups at all test points including baseline.  
Lounsberry  et  al.
28  psychoeducational  support  group  also  failed  to  find  any 
significant  improvement  within  participants‟  levels  of  subjective  distress  post 
intervention.  Finally, Gaston-Johnansson et al.
24 Comprehensive Coping Strategy 
Program found no significant treatment effect in terms of anxiety or depression.    21 
 
Physical functioning 
 
Positive  effects  were  seen  in  two  of  the  four  studies
21,24-26  measuring  physical 
functioning.  One mindfulness study,
25 symptoms of nausea and appetite problems, as 
measured by the Symptom Experience Scale (SES),
39 significantly increased over the 
treatment period, although the authors failed to report the statistical values or the 
level of distress associated with these symptoms.  Conversely, the other mindfulness 
study
21  demonstrated  statistically  significant  improvement  over  time  in  physical 
symptom distress, also measured by the SES.  The Comprehensive Coping Strategy 
Program
24 was found to be effective in significantly reducing nausea and fatigue, as 
measured  by  the  Visual  Analogue  Scale  (VAS).
42  Conversely,  Jarden  et  al.
26 
multimodal  exercise,  relaxation  and  psychoeducation  study  found  no  statistically 
significant effect for fatigue as measured by FACT-An,
40 although changes at all 
three test points following baseline favoured the multimodal intervention group but 
did not reach statistical significance.            
 
QOL 
 
No  significant  improvements  were  found  in  the  two  studies  measuring  overall 
QOL
26,28  as  measured  by  the  EORTC-QLQ–C30
44  and  the  FACT-BMT
43 
respectively.  However, Jarden et al.
26 did find a significant intervention pre-post 
effect for a specific QOL variable, reduction of diarrhoea.  Furthermore, Jarden et 
al.
26  showed that changes at all three test points after baseline for overall QOL 
favoured  the  intervention  group  but  did  not  reach  statistical  significance.    The 
psychoeducational  support  group  also  failed  to  demonstrate  any  significant 
improvements in spirituality and meaning making or positive growth.
28  Although 
positive growth, as measured by the PTGI,
46 approached significance (P = 0.055), 
however the effect size was small (d = 0.17).  In addition, The Appreciation of Life 
Subscale of the PTGI
46 showed significant change (P = 0.027) with a medium effect 
size  (d  =  0.46),  indicating  a  better  appreciation  of  life  following  the 
psychoeducational support group.    
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DISCUSSION 
 
Main findings  
 
Psychosocial  interventions  may  be  beneficial  for  HSCT  recipients.    All  eight 
included  studies  showed  positive  effects  on  one  of  more  indicators  of  QOL  or 
psychosocial  functioning,  however,  these  effects  are  inconsistent  across  studies, 
regardless of quality rating.   
 
In  terms  of  effects  on  emotional  functioning,  five  of  the  eight  studies  showed 
positive effects.  However, these studies defined emotional functioning in different 
ways  making  comparisons  and  conclusions  difficult.    Some  studies  looked  at 
depression  alone,  others  combined  depression  and  anxiety,  and  others  evaluated 
emotional functioning and distress in more global terms.  Although two of the higher 
rated quality papers reported no effect on anxiety or depression,
24,26 three other RCTs 
did report statistically significant improvement in terms of depression
23,27 and overall 
mood disturbance.
22  Furthermore, these findings are additionally complicated by 
Jarden et al.
26 sample which found depression scores within the normal range at 
baseline making it impossible to determine any potential positive or negative impact 
on anxiety and depression as a result of the multimodal intervention using exercise, 
relaxation and psychoeducation.  The findings of the pilot mindfulness studies
21,25 
suggest some possible consistency in terms of having a positive impact on anxiety 
and  depression,  however  the  poor  methodological  quality  suggests  caution  when 
interpreting  these  results.    In  general,  the  high  level  of  heterogeneity  amongst 
outcome  measures  used  increases  the  difficulty  in  interpreting  the  findings  with 
regard to positive impact on emotional functioning.        
 
In  terms  of  physical  functioning,  inconsistent  and  contradictory  findings  were 
reported regardless of quality of study.  Again, these findings are complicated by the 
use  of  heterogeneous  outcome  measures.    Notably,  in  the  two  RCTs  evaluating 
impact of intervention on fatigue, the multimodal study using relaxation, exercise 
and psychoeducation
26 that was unable to detect a statistically significant effect on 
fatigue was slightly underpowered.  This is in contrast to the Comprehensive Coping 
Strategy Program
24 which did find a statistically significant improvement and was 23 
 
not underpowered.  It may be that the Jarden et al.
26 findings reflect a Type II error 
due to being underpowered, when in fact a significant effect might have been found 
had the sample size reached power, particularly since changes in fatigue favoured the 
intervention group at all three follow-ups but did not reach statistical significance. 
 
Overall  QOL  was  the  least  frequently  measured  outcome.
26,28  However,  as 
previously  mentioned,  the  Jarden  et  al.
26  study  was  slightly  underpowered  and 
overall QOL favoured the intervention group at three follow-ups, possibly suggesting 
the  same  Type  II  error.    Interestingly,  the  statistically  significant  improvement 
reported in the Lounsberry et al.
28 study on the variable appreciation of life may 
provide further evidence for post-traumatic growth theory.
46  However, effect size 
was small and furthermore, sample size was very small (n=13) and the study did not 
have a control group.     
 
In terms of characteristics of the studies as described previously, the wide variation 
makes it impossible to ascertain the effect of variables such as duration of treatment 
or  group  vs.  individual  interventions  or  indeed  the  specific  components  of 
psychosocial interventions that may be having greatest impact on outcome.      
 
The  results  show  that  psychosocial  interventions  enhance  the  QOL  domain  of 
emotional  functioning  most  frequently  amongst  HSCT  recipients.    Physical 
functioning and overall QOL measures were less frequently used.  No measures of 
social  functioning  or  coping  were  used.    Only  one  study
28  investigated  variables 
concerning the spiritual and existential domain of QOL which is important as there is 
growing evidence to suggest positive growth following HSCT.
48  As part of a fuller 
evaluation of QOL amongst HSCT recipients, it is argued that both positive and 
negative sequelae should be assessed
48 and only one study
28 included such measures.   
  
Limitations of the review  
 
There  are  a number of  limitations of the present  review that must be  taken into 
consideration.    The  systematic  search  attempted  to  be  as  extensive  as  possible 
however the heterogeneity of the studies required the adaptation of a quality criteria 
checklist.    Although  this  was  based  on  standardised  guidelines,  validity  and 24 
 
reliability  of  scoring  would  likely  have  been  greater  had  adaptation  not  been 
required.    Furthermore,  the  inter-rater  reliability  was  based  on  only  50%  of  the 
included studies thus reducing reliability somewhat.   
 
The small number of included studies and the wide variability in design and quality 
requires  that  any  conclusions  should  be  treated  with  caution.    Due  to  the 
heterogeneity of the studies, it is difficult to compare findings and as such this review 
can  only  perhaps  suggest  the  feasibility  of  psychosocial  interventions  and 
recommend  that  efficacy  is  yet  to  be  established  through  further  research.    This 
seems important as even studies that were underpowered demonstrated statistically 
significant findings, which possibly could have achieved the level of clear statistical 
and clinical significance when adequately powered.     
   
Implications for clinical and research practice 
 
More methodologically sound studies are recommended in this area.  This could be 
achieved  in  a  number  of  ways  including  the  use  of  larger  RCTs  which  involve 
treatment and control groups that are similar and comparable at baseline.  This is 
particularly  difficult  when  working  within  the  field  of  cancer  research  given  the 
inherent heterogeneity of individuals, however, studies could address this by utilising 
the most appropriate research designs and statistical analyses.  Clearer inclusion and 
exclusion criteria such as the use of clinical cut-off scores would allow improved 
evaluation  of  the  impact  of  the  intervention  on  important  prognostic  factors.    It 
would be ideal for studies to report not only statistically significant findings but also 
clinically significant findings.  The use of follow-up designs would help achieve a 
better  indication  of  clinical  significance.    It  may  be  helpful  to  incorporate  more 
qualitative aspects when evaluating the impact of psychosocial interventions.  Pre-
defined measures of QOL and psychosocial functioning are valuable in quantitative 
research and can demonstrate clinically significant change, however, they may fail to 
detect change as defined by the individual.  Therefore, utilising satisfaction measures 
would be helpful to ascertain the value of intervention to individuals.  The type of 
psychosocial intervention relevant and clinically significant to patients is likely to 
depend on their stage of recovery therefore, monitoring of patients‟ changing QOL at 25 
 
reviews would help identify potential psychosocial needs that could be met through 
the provision of appropriate interventions.      
 
 
CONCLUSIONS 
 
In  summary,  there  is  some  preliminary  evidence  that  psychosocial  interventions 
using a variety of techniques are beneficial for the QOL and psychological wellbeing 
of HSCT recipients.  However, evidence is limited as there have been few large 
methodologically  strong  trials.    This  is  unsurprising  in  many  ways  given  the 
challenges  involved  in  conducting  fully  methodologically  rigorous  studies  with 
populations  such  as  HSCT  recipients,  who  like  many  individuals  with  cancer, 
represent  a  highly  heterogeneous  population.    Furthermore,  HSCT  recipients 
generally receive their transplants at regional cancer centres and have to travel long 
distances therefore gaining access to participants for follow-up, particularly as out-
patients, can be very difficult.  HSCT is a particularly toxic and aggressive treatment, 
associated with high mortality rates therefore attrition rates due to serious illness and 
mortality will be high. 
 
Furthermore,  the  heterogeneity  of  outcome  measures  used  indicate  caution  when 
interpreting findings as it has been demonstrated that, “Studies operationalising QOL 
from different conceptualisations frequently result in different findings even for the 
same group of people” (p. 614).
49   
 
Given the highly heterogeneous nature of the interventions and the fact that RCTs 
compared treatment groups to standard care or assessment only, it is not possible to 
draw  any  firm  conclusions  regarding  the  most  effective  specific  psychosocial 
intervention approaches.  However, this review highlights that research in this field is 
in its infancy and some of the positive findings demonstrated indicate that further 
investigation into psychosocial interventions is warranted.    
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Table 1: Quality rating of studies included in systematic review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study  Percentage %  Quality Rating 
 
Bauer-Wu et al
21  
 
48  Poor 
Cassileth et al
22 
 
92  Good 
DuHamel et al
23  
 
96  Good 
Gaston-Johansson et al
24  
 
52  Moderate 
Horton-Deutsch et al
25  
 
28  Poor 
Jarden et al
26   92  Good 
 
Kim & Kim
27  
 
88  Good 
Lounsberry et al
28 
 
44  Poor 33 
 
Figure 1 Flow  Chart of systematic review study selection process 
 
Databases searched between 
1948 - 2011using search terms: 
EBSCO 
Ovid –Medline & Embase 
Cochrane Library 
Google Scholar 
 
Hand search following journals  
2006 – 2011 
Bone Marrow Transplantation 
Psycho-Oncology 
Journal of Psychosocial 
Oncology 
 
Articles identified: n = 148 
 
Excluded n= 28 on basis of 
following criteria 
 
  Review/editorial/commentar
y papers 
  Not an adult sample 
  No original study data  
  Not a bone marrow 
transplant sample 
  No psychosocial or QOL 
outcome measure 
  A case study design 
  Not an intervention based 
study 
  A single exercise based 
intervention 
 
Publications included in 
systematic review 
 
n= 8 
 
Full copies of potentially 
appropriate articles retrieved and 
reviewed using full 
inclusion/exclusion criteria 
 
n= 36 
 
Titles and abstracts screened 
Excluded: n= 112 
 
Duplicates removed and articles 
excluded by title 
  
Table 2- Table summarizing studies included in systematic review 
 
Study   
 
Year   
 
Type  of 
Design   
 
Quality 
Rating 
 
Intervention  Recruited 
Sample 
 
Size 
 
Age  
 
Type  of 
transplant 
recipients 
Number 
Complete
d 
Treatment 
and 
followed 
up 
 
Timing  of 
Intervention 
Outcomes 
Assessed 
Outcome 
Measures 
Significant 
Results  / 
Main 
Findings 
 
Bauer-Wu  et 
al. 
21  
 
(2008) 
 
Uncontrolled 
Pilot Study  
 
Mindfulness 
Meditation 
 
 
20 
 
51 years 
 
Mixed  HSCT 
 
15 (79%) 
 
 
 
 
 
 
Began  1-3  weeks 
pre  hospitalization 
and  continued 
throughout 
hospitalization, 
which  typically 
lasted 3 weeks 
 
6  fixed  data 
collection points – 
 
Psychological 
Distress 
 
 
Physical 
symptoms 
Distress 
 
HADS 
 
 
 
SES 
 
 
fixed effect of 
time  was 
significant  (p 
<  .0001;  F  = 
7.93, 5/80 df). 
 
fixed effect of 
time  was 
significant  (p 
<  .0001;  F  = 
34
  
 
48% - poor 
 
 
 
  before  starting 
intervention,  days 
2,  and  10  of 
admission,  day  of 
discharge,  and  30 
and 100 days after 
discharge 
21.39,  5/79 
df). 
 
 
 
Cassileth  et 
al.
22 
 
(2003) 
 
RCT 
 
92% - good 
 
 
 
 
Music Therapy 
 
vs. 
 
Standard Care 
 
 
 
69 
 
Median  range 
51-53 years 
 
Autologous  
 
62 (90%) 
 
 
During  inpatient 
stay i.e. received a 
median of 5 music 
therapy  sessions 
during a median of 
10 days 
5-15 days 
 
 
Mood 
 
 
 
POMS  
 
Music 
therapy  > 
standard  care 
(P  =  0.014) 
on  the  Total 
mood 
disturbance 
score 
 
 
 
DuHamel  et 
al. 
23 
 
Telephone  - 
Cognitive 
 
89 
 
81 (91%) 
 
Survivors  of 
HSCT  who  had 
 
PTSD 
 
PCL-C 
 
T-CBT  > 
Control (t(80) 
35
  
 
(2010) 
 
RCT 
 
96% - Good 
 
 
Behavioural 
Therapy 
 
vs. 
 
Assessment 
Only  Control 
Group 
 
 
 
Intervention  = 
52.19  (27-71) 
years;  Control 
= 49.38 (19-74) 
years 
 
 
Intervention  - 
Autologous  = 
28;  Allogeneic 
= 17; missing = 
2;  
 
Control  – 
Autologous  = 
12;  Allogeneic 
=  18;  Missing 
= 4 
 
 
undergone  HSCT 
1-3 years earlier 
 
Follow-up  at  6,  9 
and  12  months 
following baseline 
 
 
10-16  weeks 
intervention 
 
10 sessions 
 
 
 
 
 
 
 
 
 
 
 
Distress 
Symptoms 
 
 
 
 
 
 
(intrusive 
thoughts 
subscale) 
 
 
PCL-C 
(avoidance 
subscale) 
 
 
 
 
BSI 
(general 
distress) 
 
 
 
 
 
=  2.60;  P  = 
0.011) 
 
 
 
T-CBT  > 
Control (t(80) 
=  3.95;  P  < 
0.001) 
 
 
 
T-CBT  > 
Control 
(F(4,80)  = 
4.05;  P  = 
.005)  
 
 
 
 
 
36
  
Depression 
 
BSI 
(depressive 
symptoms) 
 
 
T-CBT  > 
Control 
 (F(4,208)  = 
2.89;  P 
=.023) 
 
Gaston-
Johansson  et 
al. 
24 
 
(2000) 
 
RCT 
 
52%  - 
Moderate 
 
 
 
Comprehensiv
e  Coping 
Strategy 
Program 
(CCSP) 
 
vs. 
 
Treatment  as 
Usual (tau)  
 
 
110 
 
22-51 years 
 
Autologous 
 
110 
(100%) 
 
During 
hospitalization 
 
CCSP  taught  to 
patients  2  weeks 
pre-admission  and 
reinforced  on  3 
further occasions 
 
 
 
Anxiety 
 
 
 
Depression 
 
 
 
Pain 
 
 
 
 
 
STAI 
 
 
 
BDI 
 
 
 
POM  
 
 
 
 
 
Non-
significant 
 
 
Non-
significant 
 
 
Non-
significant 
 
 
 
 
37
 
37
  
Nausea 
 
 
 
 
 
Fatigue 
VAS  
 
 
 
 
 
VAS 
CCSP  >  tau 
(ß  =  -16.94; 
[beta] = 0.27; 
p < 0.05  
 
 
 
CCSP  >  tau 
(ß  =  -26.23; 
[beta]  =  -.27; 
p < 0.05)  
 
Horton-
Deutsch  et  al. 
25 
 
(2007) 
 
Uncontrolled 
Pilot Study 
 
28% - Poor 
 
Mindfulness-
Based 
Therapeutic 
Intervention 
 
 24 
 
18-75 years 
 
Mixed 
Autologous 
and Allogeneic 
 
15 (62.5%) 
followed 
up 
 
During 
participants‟ 
hospital  stay  over 
course  of  3  -4  
weeks:    twice 
weekly  20  –  40 
minute  individual 
patient sessions 
 
6-8  bi-weekly 
sessions 
 
Psychological 
and  Emotional 
problems 
 
PANAS 
 
 
 
 
 
 
 
 
 
Significantly 
lower 
negative 
affect  scores 
post 
intervention.  
Positive 
affect  change 
non-
significant 
 
 
 
38
  
 
 
 
HADS 
 
 
 
SES 
 
 
 
 
 
 
Non-
significant 
 
 
Nausea  & 
appetite 
problems 
significantly 
increased 
 
Jarden et al.
26  
 
(2009) 
 
RCT 
92% - Good 
 
 
Multimodal 
intervention: 
exercise, 
relaxation  and 
psycho 
education 
vs. 
usual care 
 
  
42 
 
39.1  years 
(mean) 
 
Allogeneic  
 
 
Post  =  34 
(81%) 
 
3months  = 
29 
 
6months  = 
28 
 
4-6 week program 
in  hospital  –  took 
place  5  days 
weekly 
Four  time  points; 
baseline,  post-
intervention,  3- 
and  6-  month 
follow up 
 
QOL 
 
 
 
 
 
 
 
EORTC QLC 
–C30 
(global) 
 
EORTC QLC 
–C30 
(diarrhea) 
 
 
Non-
significant 
 
 
Multimodal 
intervention > 
usual  care  (P 
= 0.014)  
39
  
 
 
 
 
 
 
 
   
 
 
 
 
Fatigue 
 
 
Psychological 
wellbeing 
 
 
 
 
FACT-an  – 
fatigue 
 
 
HADS 
 
 
 
 
Non-
significant 
 
 
Non-
significant 
 
Kim & Kim
27  
 
(2005) 
 
RCT 
 
88% - Good 
 
 
 
Relaxation 
Breathing 
Exercise 
 
vs. 
 
Routine Care 
 
 
 
42  
 
RBE  –  32.9 
years (mean) 
 
Routine Care – 
34.3  years 
(mean) 
Allogeneic 
 
35 (83%) 
 
 
 
Provided daily for 
6  weeks  during 
hospitalisation 
 
 
 
Anxiety 
 
 
 
 
Depression 
 
STAI 
 
 
 
 
BDI 
 
RBE  > 
routine  care 
(P = .0001)  
 
 
 
RBE  > 
routine  care 
(P = .0001) 
 
40
  
 
 
 
 
 
 
 
Lounsberry  et 
al. 
28 
 
(2010) 
 
Uncontrolled 
Pilot Study 
 
 
44% - Poor 
 
 
 
Psycho-
educational 
support group 
 
 
 
 
19  
 
 
Mean  age  = 
45.8  years 
(range 19-66) 
 
Allogeneic 
 
 
13 (68%) 
 
Survivors  0  –  3 
years  post 
transplant 
 
6  weekly,  1.5  hr 
group 
videoconference 
sessions 
 
 
 
Quality of Life 
 
Spiritual 
Meaning 
Making 
 
Subjective 
Distress 
 
Perception  of 
Personal 
Benefits  that 
occur as a result 
of  attempts  to 
cope  with 
treatment 
 
FACT-BMT 
– Qol 
 
FACIT - Sp 
 
 
IES-R 
 
 
PTGI 
 
Non-
significant 
 
Non-
significant 
 
Non-
significant 
 
Non-
significant 
but 
Appreciation 
of  life 
subscale 
showed 
significant 
change (Z = -
2.21,  P  = 
0.027) with a 
medium 
effect  size  (d 
= 0.46)  
41
  
Key: 
 
SES – Symptom Experience Scale (Samarel et al., 1996) – consists of symptoms commonly experienced by cancer patients and 
describes symptoms frequency, intensity and distress, each rated on a 0-4 scale.  Six subscales include nausea and appetite, fatigue and 
sleep, concentration, appearance, bowel function and pain; 
 
HADS – Hospital and Anxiety Depression Scale (Zigmond & Snaith., 1983) – is a 14 item self-report measure with two 7-item 
subscales assessing anxiety and depression, or a combined total score of psychological distress.  For use in investigations in patients 
with physical illness. 
 
POMS – Profile of Mood States (McNaire et al., 1992) – widely used QOL measure.  Self administered instrument combined of 65 
adjective rating scales that assess transient mood states.  The scale was developed for repeated use to measure change over time.  
Scores are obtained for six factorially derived mood or affective states:  Tension-Anxiety; Depression-Dejection; Anger-Hostility; 
Vigor-Activity; Fatigue-Inertia; and Confusion-Bewilderment.  A total mood disturbance score is obtained as the sum of all six factor 
scores after weighting Vigor negatively. 
 
PCL-C – PTSD Checklist Civilian Version (DuHamel, Ostroff, Ashman et al., (2004); Weathers,  Litz, Herman et al.,  (1993)  – 
measure of illness-related PTSD symptoms previously used with HSCT survivors.  Yields  a total score and subscale scores  for 
intrusive thoughts, avoidance, numbing and hyperarousal. 
 
42
  
BSI – Brief Symptom Inventory (Derogatis, 1993) – is a questionnaire that assesses general psychological distress.  Subscales include 
Global Severity Index and the depression subscale. 
 
POM – Gaston-Johansson Painometer (Gaston-Johansson, 1996), designed to assess patients; overall pain intensity, the intensity of 
the sensory and affective components of pain, and the quality of pain. 
 
VAS – Visual Analogue Scale (Gift, 1989), is a valid, reliable, and sensitive self-report tool for studying subjective symptoms. 
 
STAI – The State-Trait Anxiety Inventory (Spielberger, Gorsuch & Lushene, 1971).  Consists of two separate self-report scales for 
measuring state and trait anxiety.  State anxiety is a transitory emotional response to a stressful situation.  Trait anxiety reflects a stable 
predisposition to anxiety as determined by a personality pattern.  Respondents rate themselves in relation to the statement on a Likert 
Scale from 1 to 4.  The total score is the sum of all 20 responses and ranges from a minimum score of 20-39 (low anxiety) to 40-59 
(moderate anxiety) to a maximum score of 60-80 (high anxiety) 
 
BDI – The Beck Depression Inventory (Beck & Steer, 1993), consists of 21 items that describe particular symptoms of depression.  
Subjects respond to a Likert – type scale by rating each item 0 (no distress) to 3 (severe or persistent presence of the symptom).  
Scores range from 0-9 (normal) to 10-15 (mild depression) to 16-23 (moderate depression) to 24-63 (severe depression).  The total 
score (range, 0-63) is obtained by summing the 21 responses. 
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PANAS – Positive and Negative Affect Scale (Watson, Clark & Tellegen, 1988) –  is a 20-item self-report measure of positive and 
negative affect 
 
EORTC –QLQ – C30 – The European Organization for Research and Treatment Cancer Quality of Life Questionnaire, Aaronson, 
Ahmedzai, Bergman et al., 1993).  Comprises of 30 items to assess QOL in cancer patients 
 
FACT – an – Functional Assessment of Cancer Therapy – Anemia scale (Yellen, Cella, Webster et al., 1997).  Designed to measure 
the extent of fatigue. 
 
FACT – BMT – Functional Assessment of Cancer Therapy – Bone Marrow Transplant (McQuellon, Russell, Cella et al., 1997).  
Measures five dimensions of QOL specific to HSCT population:  Physical well-being; Social/Family wellbeing; Functional wellbeing; 
and additional concerns. 
 
FACIT – Sp – Functional Assessment of Chronic Illness Therapy – Spiritual Wellbeing (Peterman, Fitchett, Brady et al., (2002).  
Used to assess impact of intervention on participant spirituality and meaning making.  QOL measure. 
 
IES-R – Impact of Event Scale – Revised (Weiss & Marmar, 1997) – used to measure subjective distress related to a particular event. 
 
PTGI – Post-Traumatic Growth Inventory (Tedeschi & Calhoun, 1996) – used to evaluate the perception of personal benefits that 
occur as a result of attempts to cope with treatment. 
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Lay Summary 
Blood cancers and related disorders are most commonly diagnosed in adults over fifty 
years old.  However, until very recently adults over fifty were considered too high risk 
to  receive  a  particular  type  of  bone  marrow  transplant  known  as  allogeneic 
haematopoietic stem cell transplant (HSCT), which has the potential to cure the disease.  
This is because HSCT is an extremely aggressive cancer treatment which means patients 
have to spend long periods in hospital and experience a lengthy recovery period.  As a 
result normal life is often put on hold for a time.  Research has shown that the treatment 
can have a significant impact on younger patients‟ quality of life.  However, very little is 
known about what the experience of this transplant is like for older adults (50 years or 
more).  Therefore, this study aims to explore the experience of QOL after HSCT for 
patients  aged  over  fifty  in  order  to  help  increase  our  knowledge  and  help  to  better 
inform potential patients of ways in which life may be impacted after transplant.              
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Abstract    
 
Background:  Allogeneic Haematopoietic stem cell transplant (HSCT) is a potentially 
curative treatment for haematological cancers however it is a particularly aggressive 
treatment that can impact individuals‟ quality of life (QOL) in multiple ways.  Due to 
the toxicity of the transplant, adults aged over fifty years have only recently become 
eligible for this treatment following the development of a reduced intensity regimen.  As 
a result, little is known regarding the experience of QOL among recipients aged over 
fifty years.  QOL information is an essential part of assessing the success of medical 
treatments and can help prepare recipients for any ways in which their lives and those of 
their families may be impacted post-transplant.    
  
Method 
Potential  participants  were  recruited  through  the  Beatson  West  of  Scotland  Cancer 
Centre (BWSCC) and a purposive sample of eight participants volunteered to take part 
in the study.  A qualitative approach,  Interpretative Phenomenological  Analysis was 
used to explore the experience of QOL among recipients.     
 
Results  
Four superordinate themes emerged from the data; „Shifting sense of self and others‟, 
„Adaptation  and managing the impact‟, „A new perspective on life  and living‟, and 
„Changing  over  time‟.    The  findings  helped  highlight  the  challenges  and  gains 
experienced by HSCT recipients as well as the process of adaptation and adjustment 
which mediates the impact of HSCT on QOL.   
 
Conclusions 
The participants in this study demonstrated that there are a number of commonalities 
between younger and older recipients in terms of post transplant QOL when compared 
to the literature on younger recipients to date.  However, increased age and stage of life 
was also shown to have a unique impact on the subjective experience of QOL after 
transplant.  Increased age continues to represent a significant risk factor in terms of 48 
 
QOL and survival post transplant.  However, the findings from this study suggest that 
this small sample of recipients is adjusting well to the challenges of HSCT.  Further 
research is required in this area.  Limitations of this study are discussed.     
 
Keywords:  haematopoietic stem cell transplant, quality of life, allogeneic, qualitative  
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Introduction 
 
Cancer and the treatment of cancer affect all aspects of patients‟ lives.  For patients 
diagnosed  with  a  haematological  cancer,  allogeneic  haematopoietic  stem  cell 
transplantation (HSCT) is a treatment option with curative potential.  Due to the highly 
toxic  nature  of  the  treatment,  conventional  allogeneic  HSCT  is  contraindicated  for 
people  over  the  age  of  55.  Haematological  cancers,  however,  are  very  common  in 
people over this age, with the median ages of diagnosis ranging between 55 and 70 years 
[1].  In the late 1990s a reduced intensity conditioning (RIC) regimen was developed as 
an alternative to conventional HSCT [2].  This means that an increasing number of older 
adults are now able to receive allogeneic transplants. 
 
The importance of evaluating quality of life (QOL) issues among survivors of cancer is 
now well recognised and a growing body of research has increased our knowledge of the 
impact  of  allogeneic  HSCT  on  the  lives  of  younger  adult  survivors  [3,4].    Despite 
medical  advancements  contributing  to  improved  outcomes  for  patients,  allogeneic 
HSCT  remains  an  aggressive  and  taxing  treatment  associated  with  physical  and 
psychosocial  sequelae  such  as  fatigue,  persistent  anxiety  and  depressive  symptoms, 
sexual dysfunction and fertility concerns [4].  As allogeneic HSCT uses healthy donor 
stem cells to restore blood cell production, this can result in graft-versus-host disease 
(GvHD).  GvHD occurs when donor cells attack the patient‟s organs, precipitating a 
potentially life threatening condition.  Furthermore, due to the often lengthy recovery, 
most adult recipients experience some interruption in normal developmental tasks, for 
example,  maintaining  a  career  and  establishing  satisfactory  marital  and  family 
relationships  [5].    Therefore,  HSCT  is  a  treatment  which  affects  all  aspects  of 
individuals‟ lives.  
 
Despite the many physical and psychosocial challenges presented by HSCT, a recent 
systematic  review  identified  that  some  survivors  report  positive  changes  in  QOL 
including an enhanced appreciation for life, different priorities, love and appreciation for 50 
 
family and friends, and greater religious or spiritual beliefs.  These reported benefits are 
unrelated to physical functioning and other QOL indices [3].   
 
It seems, therefore, that HSCT may impact both positively and negatively on both the 
recipient‟s life and that of their family and  friends.  It  has  been recommended that 
receiving HSCT should be conceptualised as a psychosocial transition period that offers 
the potential for growth [36].  Therefore in terms of research into the impact of HSCT 
on QOL, positive impact  should also  be explored.  Qualitative measures  have been 
invaluable  in  identifying  such  positive  themes,  changes  and  outcomes  [6,  7].    It  is 
recommended  that  more  qualitative  studies  should  be  conducted  within  the  field  of 
HSCT, especially in the absence of good quantitative measures, and that these studies 
should ask about positive and negative outcomes [8].  Most QOL quantitative measures 
specific  to  HSCT  are  designed  to  detect  negative  changes  in  functioning  and  are 
consistent with the „stress‟ paradigm. 
 
Research in this field has tended to be quantitative studies using a variety of measures 
and  methodological  designs.    However,  the  measurement  of  QOL  among  HSCT 
recipients  remains  a  controversial  issue  due  to  the  lack  of  agreement  regarding  the 
conceptual and operational definition of QOL.  Furthermore, the lack of a gold standard 
for measuring QOL frequently translates into difficulty interpreting and synthesising 
research findings [9]. 
 
In response to some of the limitations of quantitative research investigating the impact 
of HSCT on recipients‟ lives, a small body of research has used qualitative approaches 
in order to gain a more in depth understanding of patients‟ experiences with HSCT [6, 7, 
10,  11].    This  research  focused  on  exploring  the  QOL  experienced  by  recipients 
following different types of HSCT and highlighted issues relevant to survival that were 
not particularly well covered or addressed in standardised questionnaires.  Even this 
qualitative research, however, focused on younger adults (mean age at time of transplant 
29, 32 and 31 years, respectively).  These studies mentioned that the QOL implications 
for  younger  recipients  may  differ  from  those  experienced  by  older  recipients  [10].  51 
 
While the main domains of QOL identified in the literature are relevant to adults of all 
ages, these can vary in priority among people in different age groups [12].  
 
Experts in the field of HSCT point out that although we are moving forward in our 
understanding of the impact of transplant on QOL in younger people, generally, little 
evidence exists to guide our understanding of the impact of HSCT on recipients aged 55 
years or more [13, 14].  Researchers recommend caution in applying evidence in new 
populations  such  as  those  aged  over  55  years  [13].    Experts  also  argue  that  it  is 
important to consider sub-groups of transplant recipients (i.e. allogeneic vs. autologous) 
due to the unique ways transplant can shape the symptom experience, functional status, 
psychosocial health, and QOL of recipients [15].  This is particularly relevant for adults 
over 55 receiving this new transplant who are not only at a higher risk of relapse but are 
also  considered  a  high  risk  population  due  to  the  increased  likelihood  of  GvHD, 
opportunistic infection, and transplant-related morbidities [16].  Research has shown 
that  the  patient  experience  with  RIC  HSCT  is  distinct  in  comparison  with  other 
transplant populations, due to the medical risks as well as the effects of physical ageing 
[17].    These  factors  may  make  this  group  of  patients  different  to  other  transplant 
recipients.   
  
With so many potential consequences in all areas of life, it is crucial to investigate older 
recipients‟ perceptions of their treatment and of themselves in order to identify any areas 
for intervention.  Given some of the limitations of QOL quantitative methodologies 
which pre-define the construct and ask “what” has changed according to predefined 
categories, a qualitative approach using Interpretative Phenomenological Analysis (IPA) 
has been chosen as an alternative method as this allows people to describe their own 
perceptions of how life has been impacted and the personal, subjective meaning of any 
changes.  By accessing underlying cognitions, such as beliefs and attitudes, this may 
help us shed light on a person‟s behaviour and experience [18].  This is important for the 
purpose of this study since it may be that individuals‟ perceptions and appraisals of any 
changes impact their experience of QOL.   An in-depth understanding of the “objects of 
concern” in participants‟ worlds is required in order to build our knowledge of patients‟ 52 
 
experience with this newly developing treatment.  IPA was chosen for this study, in 
preference to other qualitative approaches, due  to its concern with the conducting a 
detailed examination of human lived experience, expressed in its own terms rather than 
according to predefined category systems [19].  This makes this approach particularly 
appropriate for investigating QOL after HSCT.   
 
Qualitative studies in which survivors provide their own accounts of their experiences 
have been recognised as a valuable method for use with other sub-groups of younger 
recipients;  however, the experiences of older recipients receiving a newly developed 
transplant procedure are lacking.  The present study, therefore, attempts to elaborate the 
experience of QOL following HSCT and takes the lead from HSCT patients who have 
reported their dislike of aspects of standardized QOL questionnaires for reasons such as, 
they “did not address spiritual life, changes in perspective etc.”, “put words in mouth” 
“should be more in depth” and “asked specific questions with no place for explanation” 
[20 p. 152-153]. 
 
This study is interested in how older recipients experience the challenges of HSCT.  
Given that adults over 55 receiving RIC HSCT are considered to be a distinct recipient 
population with unique needs, it is essential to explore their subjective experiences of 
this life-changing event.  Therefore, the present study aims to:  
1.  Explore participants‟ personal meanings and experiences (positive and negative) 
of QOL following RIC HSCT. 
2.  Identify areas for intervention depending on experiences unique to older patients 
(55 + years) having this type of transplant.   
 
This study comes at an exciting time in the field of HSCT, as advances in medical 
science have extended the use of transplant, allowing a much wider range of individuals 
to undergo this potentially curative treatment.  Indeed, in their 2009 committee report 
Murphy et al. [16], stress the paucity of cancer research addressing the very unique 53 
 
needs of adults over 55 years undergoing allogeneic HSCT and argue that studies should 
investigate the effects of age on the experience of QOL.  An understanding of patients‟ 
experience with HSCT within this changed context is critical in order to help prepare 
patients for ways in which life may change following transplant.  This would allow for 
better  informed  consent.    It  would  also  help  identify  any  areas  for  intervention 
depending on the worries, stresses or distress unique to patients having this type of 
transplant.      
 
Method 
 
Design 
 
This qualitative study employed IPA which has its theoretical roots in phenomenology, 
hermeneutics and idiography [19].  IPA is concerned with the detailed examination of 
personal  lived  experience,  the  meaning  of  the  experience  to  participants  and  how 
participants make sense of that experience [21].  IPA aims to explore the participant‟s 
experience from their perspective but the method recognises that the phenomenological 
analysis  produced  by  the  researcher  is  always  as  interpretation  of  the  participant‟s 
experience [18].  This is referred to as the “double hermeneutic”, whereby the researcher 
is trying to make sense of the participant making sense of what is happening to them [21 
p. 10].  This makes the role of the researcher particularly significant in IPA therefore 
reflexivity is a meaningful part of write up, as will be elaborated upon within the method 
section. 
 
IPA  has  become  one  of  the  best  known  and  most  commonly  used  qualitative 
methodologies in psychology and research investigating illness experience [21].  IPA 
was chosen as the preferred qualitative approach due to its focus on personal meaning 
and  sense-making  in  a  particular  context,  for  individuals  who  share  a  particular 
experience.  This is in contrast to other qualitative approaches such as Grounded Theory 
[39], for example, which aims to identify and explain in detail, contextualised social 
processes and factors which account for phenomena.  IPA is instead concerned with 54 
 
gaining a better understanding of the quality of individual experiences; that is,  it  is 
interested in the nature or essence of phenomena [18; p.69].  
Participants and recruitment method 
 
The goal of qualitative studies is to capture the breadth of possible patient attitudes or 
experiences.  In contrast to quantitative studies in which generalisability is critical, the 
goal of qualitative studies is not to obtain a statistically representative sample, but rather 
to achieve “symbolic representation” [22].  Therefore purposive sampling was used to 
recruit participants because they are the experts in the phenomenon being explored.   
IPA is particularly suited to the analysis of small samples due to its focus on generating 
information-rich, in-depth knowledge of a particular phenomenon.  For the purpose of 
conducting a Doctorate in Clinical Psychology (DClinPsy) thesis, Turpin et al. [23] state 
that a sample size of 8 is feasible and appropriate.   
 
Participants were considered eligible to participate in the study if they had received a 
specific  RIC  HSCT  from  an  unrelated  donor  at  least  6  months  prior  to  interview.  
Medical experts at the Beatson West of Scotland Cancer Centre (BWoSCC) advised this 
time frame as it would allow acute health problems to resolve and the normal recovery 
process to have begun.  Eligibility criteria also specified that participants be aged 50 or 
more at time of transplant; that disease was controlled and no relapse of disease had 
occurred.  As recommended by Smith, Flowers & Larkin [19], the participants in this 
study represented a reasonably homogenous, purposive sample.   
 
Haemato-oncology medical staff working with patients undergoing RIC HSCT reviewed 
the  database  which  revealed  that  approximately  30  individuals  aged  over  50  had 
received and survived an unrelated RIC HSCT within the last 6 years.  Of this sample, 
12 met inclusion criteria.  Potential participants were then informed of the study by their 
Senior  Nurse  Specialist  and  given  the  information  sheet.    Participants  interested  in 
taking part were then invited to telephone the researcher directly.  Eight participants 
expressed their interest in participating.  During the data collection process it became 
apparent that 5 participants were being reviewed at the BWoSCC but that others were 55 
 
being reviewed by Consultants in their local geographical areas due to the significant 
distance from Glasgow.  This is because the BWoSCC is the only centre in Scotland to 
perform RIC HSCTs, so often recipients only attend the BWoSCC annually and have 
more  frequent  review  appointments  within  their  local  geographical  area.    Given 
participants‟ desire to be involved in the study, it was decided that conducting telephone 
interviews would be an appropriate alternative to conducting face to face interviews.  
Indeed, participants themselves suggested this alternative.   
 
Participants were 5 males and 3 females.  Their mean age at time of HSCT was 58 years 
(range = 52 – 63 years).  Survival time since transplant to interview ranged from 10 
months to 73 months (mean survival time = 33.9 months).  Participants had undergone 
HSCT  for  a  variety  of  haematological  cancers  and  related  life  threatening  blood 
disorders.  All participants received allogeneic RIC HSCT from an unrelated donor.  
Table 1 gives a summary of participant characteristics and reported side-effects as a 
result  of  transplant.  All  participants  have  been  allocated  a  gender  appropriate 
pseudonym.  Although one participant was receiving top-up lymphocytes to help control 
the disease and one participant had recently received a secondary diagnosis of breast 
cancer, it was decided that this would not affect the homogeneity of the sample as these 
individuals  had both  experienced HSCT which had controlled their original disease.  
Furthermore,  receiving  top-up  lymphocytes  is  considered  part  of  standard  protocol 
following RIC HSCT and indeed a number of participants also received such follow-up 
treatment  at  various  stages  of  recovery.    The  research  question  was  therefore  still 
important for these participants and it was decided that their inclusion would enrich the 
findings.  
       
Table 1.  Characteristics of participants 
Name  Age at 
HSCT 
(years) 
Time since 
HSCT 
(months) 
Disease Type  Reported Adverse physical 
effects of HSCT 
Type of 
Interview 
James  55  11  Myelofibrosis  GvHD (L229) 
Reduced muscle mass 
(L115) 
Infections (L224) 
Taste buds and salivary 
glands affected (L151) 
Face-to 
face 
Helen  61  44  Acute Myeloid  None reported  Face-to 56 
 
Leukaemia (AML)  Recent secondary diagnosis 
of breast cancer (L51) 
face 
Mary  59  30  Myelodysplasia 
(MDS) 
Fatigue (L370) 
Frequent infections (L257) 
Face-to 
face 
Paul  52  28  Chronic Myeloid 
Leukaemia (CML) 
Pain (L701) 
Muscle weakness and aching 
(L714) 
No immune system (L964) 
“there always seems to be 
something wrong.  Ken, if 
it‟s not the cold I‟ve got, it‟s 
– there‟s something”  (L719) 
Face-to 
face 
David  60  10  Myelodysplasia 
(MDS) 
Fatigue (L294) 
Receiving venosections to 
remove excess iron (L323) 
Hearing and vision 
impairment (L325) 
Infections (L327) 
Balance and coordination 
problems (L337) 
Face-to 
face 
Geoff  61  18  B-cell chronic 
lymphocytic 
leukaemia (B-CLL) 
Fatigue (L190) 
Reduced immune system 
(L271) 
Telephone 
Isobel  54  73  Lymphoma  Fatigue (L554) 
Slowed mobility (L262) 
Reduced muscle strength 
(L246) 
Chest cyst (L334) 
Still requiring venosections 
to reduce excess iron levels 
(L160) 
 
Telephone 
Harold  63  57  Myelofibrosis  Triggered Diabetes related 
problems (L126) 
Reduced physical capacity – 
balance, muscular tone and 
strength (L185) 
Impaired vision (L207) 
Impaired kidney function 
(L180). 
 
Telephone 
  
Procedure 
 
  Ethics 
   
The study was carried out in accordance with the British Psychological Society‟s (BPS) 
Code  of  Ethics  and  Conduct  [24].    Prior  to  commencement  the  study  underwent  a 
standard two-step process to receive organisational approval from the BWoSCC (see 57 
 
Appendix 2.2).  Full ethical  approval  was  also obtained from  the West  of Scotland 
Research  Ethics  Committee  (appendix  2.3)  and  management  approval  from  Greater 
Glasgow  and  Clyde  Research  Development  was  received  (see  Appendix  2.4).  
Participants were fully informed (see Appendix 2.5 for information sheet) about the 
research aims and procedure and they gave their consent prior to data collection (see 
Appendix  2.6).    Subsequent  ethical  approval  was  obtained  to  conduct  telephone 
interviews for participants who could not travel to Glasgow for interview (Appendix 2.3 
and 2.4).  Written consent for participation, recording and transcribing of interviews as 
well  as  publishing  of  anonymised  quotations  was  sought  from  all  participants  (see 
appendix 2.6).  To ensure anonymity, each participant was given a gender appropriate 
pseudonym and all identifying information was removed.   
 
  Data collection 
   
Data  were  collected  through  semi-structured  interviews.    The  lengths  of  interviews 
ranged  between  46  and  75  minutes  (average  65mins)  and  were  recorded  for  later 
transcription.  Participants were encouraged to talk as widely as possible about their 
experiences of life after HSCT and the researcher made it clear that there were no right 
or wrong answers, simply a personal account of their own views and feelings.  The 
researcher‟s clinical skills of active listening and empathy were given primacy on order 
to remain participant led as much as possible.  The researcher kept a reflective diary 
throughout data collection in order to help facilitate questioning style for subsequent 
interviews but also to help retain the essence of the individual‟s account which would be 
later interconnected with others‟ experiences.  All eight transcripts were then transcribed 
verbatim and included non-linguistic elements, for analysis.    
 
Interview schedule 
 
The interview schedule (Appendix 2.7) was developed based on a review of the relevant 
literature and current issues within the field of QOL among HSCT recipients.  Research 
has shown that when asked about changes in general participants may be more likely to 58 
 
report more negative than positive changes out of habit or demand characteristics [25].  
Therefore, the interview schedule included open-ended questions about both positive 
and negative outcomes as recommended by Bishop and Wingard [8].   
       
Open-ended and non-directed questions were developed to encourage participants to talk 
as widely as possible about their experiences of life after transplant.  The development 
of  the  schedule  and  interviewing  style  was  influenced  by  the  guidance  provided  in 
Smith, Flowers & Larkin‟s [19] text, which is particularly useful for IPA researchers.  
The interview schedule was not adhered to rigidly but rather used as a guide to help 
prompt  deeper  exploration  of  issues  and  was  utilised  in  a  flexible  manner  with 
participants.  In order to try and give specific focus to the interviews and address the 
“objects of concern” within participants‟ experiences, a core question was asked of each 
participant,  “what  does  the  term  QOL  mean  to  you?”    This  was  asked  to  help 
participants define their own meaning of the construct and then go on to consider their 
perceptions of any ways they felt life had changed since transplant.  The researcher was 
then  able  to  be  led  by  participants  in  terms  of  following  up  on  different  domains 
pertinent to their QOL such as family life, social, ability to enjoy life, relationships with 
others  etc.    This  allowed  participants  to  retain  the  expert  stance  and  describe  their 
experiences on their own terms whilst ensuring the issues of interest were addressed.  
  
Analysis 
 
Analysis  of  the  data  was  conducted  according  to  the  guidelines  outlined  by  Smith, 
Flowers & Larkin [19] which are particularly valuable to novice IPA researchers and 
can help maximise rigour.  This process was idiographic whereby one transcript was 
examined in detail before going on to examine others.  The first stage was to become 
immersed in the data by reading and re-reading the data, initially listening to the audio 
recording simultaneously.  The second stage involved producing a comprehensive and 
detailed set of notes focusing on descriptive, linguistic and conceptual comments.  These 
were written on the right hand margin of the transcript.  Emergent themes were then 
noted on the left hand margins which were expressed as phrases or words that were 59 
 
more  conceptual  in  nature,  for  example,  “using  coping  strategies”  or  “family  life 
disrupted”.    This  process  was  repeated  for  each  individual  transcript.    For  each 
transcript, a full set of emergent themes was constructed and grounded in quotations 
from  the  text.    Given  the  larger  sample  size,  the  researcher  held  off  the  search  for 
patterns (as much as was possible) until examining all the cases together.  In order to 
keep with  IPA‟s  idiographic commitment, it was  important  to  allow new themes to 
emerge with each new case, which is challenging, but the steps outlined help minimise 
being overly influenced by what has emerged so far.  The last stage involved searching 
for  patterns  and  connections  across  cases  and  emergent  themes  were  then  clustered 
together to produce a master list of superordinate themes.  At this stage, measuring 
recurrence across cases is important.  For the purpose of this study, recurrence of an 
emergent theme is defined as being present in at least half of participants‟ interviews.  
Please see Appendix 2.9 for a summary table showing how themes were developed.    
     
Reliability and Validity 
 
In order to minimise interpretative bias, the first 3 transcripts were coded blindly by an 
experienced qualitative researcher who had no professional knowledge of this group of 
participants.  This second researcher also found the same emergent themes from the 
data.  Furthermore, emergent themes presented are supported by the participants‟ actual 
quotes  in  order  that  the  reader  can  assess  the  reliability  and  validity  of  the 
interpretations.  
     
Reflexivity 
 
Personal reflexivity is important when conducting IPA studies due to the potential for 
interpretative bias.  I have not worked within a psycho-oncology setting but have had 
personal experience of family and friends who have had cancer.  As such, I have been 
able to appreciate the complexity of experiences of life after treatment and the gains and 
losses inherent to survival.  As a thirty year old woman who has been so fortunate to 
have never faced such life-threatening illness, I am acutely aware of my own stage of 60 
 
life  priorities  and  concerns.    However,  having  completed  an  older  adults‟  specialist 
placement during my DClinPsy training, I hope that my understanding and awareness of 
ageing  process  involving  both  challenges  and  opportunities  has  helped  me  retain  a 
balanced and open-minded approach to analysis.   
        
Reflections upon interviews 
 
Although the aim of my study was to gain an in-depth understanding of participants‟ 
perceptions  of  how  HSCT  had  impacted  their  QOL,  I  found  very  quickly  that 
participants would quite factually mention some of the things they felt they were doing 
less of in terms of hobbies and activities.  Although they spent some time elaborating on 
the meaning of this changed physical existence, I found that they tended to then focus on 
how they cope and adapt to change.  This seemed to represent a slight deviation from 
the research agenda but also provided information-rich and experiential data particularly 
amenable  to  IPA.    As  such,  the  research  question  slightly  shifted  from  being  an 
exploration of the meaning of the impact to include an exploration of their adaptation to 
the impact.  
 
One  other  important  experience  encountered  during  the  interviews  was  with  one 
participant who felt it important to focus on her experiences of living with cancer for a 
number of years in an in-depth manner that produced much rich information for IPA but 
unfortunately  produced  very  limited  data  in  relation  to  the  experience  of  life  after 
HSCT.  Her account was compelling and moving and perhaps best captured by the 
following recollection of being told the leukaemia was “winning” and that there was no 
further treatment that could be offered to her: 
 
“Do you mean to say I‟m going to die?”  He said, “yes”.  [pause].  He said, I said, 
“And  what  happens  now?”  and  he  said,  “oh…we‟re  moving  you  to  the  hospice 
tomorrow” [pause] and that was that.” Helen [L260].   
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This woman struggled to describe her experience of life after transplant and again is 
reflected in her statement: 
 
“Well, I think what affected the bone marrow transplant is what went before.” [L90].  
  
As a result, this woman‟s experiences may appear less frequently within the results due 
to her desire to share her experiences of her journey towards finally being accepted for 
HSCT and her preference not to be guided by my research interests but her own most 
meaningful experiences of living with cancer: 
 
 “I‟ll leave the bone marrow transplant and go back to when I was diagnosed?  If that‟s 
ok?” [Helen; L202] 
 
Results 
 
Setting the scene 
 
Before participants began describing their perceptions of QOL and wellbeing following 
transplant, all spent some time describing their experiences of being diagnosed with a 
life-threatening illness that would result in loss of life without treatment.  The majority 
of participants talked about the fact that they had been treated with different drug trials 
however these were unsuccessful in controlling the disease for any length of time.  Four 
participants reported that they requested HSCT from their medical team.  All but one 
participant reported their awareness of age as a possible precluding factor and described 
therefore having to go through a process of approval for HSCT.  They all described 
being acutely aware of the risks of transplant but felt they had “no choice”; it would be 
“fatal” otherwise. For participants who had experienced longer histories of illness, they 
described being offered HSCT as meaning that there was finally “light at the end of the 
tunnel”.  All participants received a transplant using an unrelated donor‟s stem cells.  
For many, they described how lucky they felt that they had been able to find a match to 
permit the transplant.  They also talked about their awareness of the rarity of this type of 62 
 
procedure being used with adults of their age.  All but one participant described living 
with a variety of physical health impairments as a direct or indirect result of HSCT (See 
Table 1).  These adverse physical effects were often described in a factual manner and 
not particularly amenable to IPA.  Given the restrictions of the scope of this DClinPsy 
thesis, it was decided that analysis should focus on how participants make sense of their 
experiences.  Although  some  of  these  scene-setting  views  and  experiences  are  not 
directly related to answering the research question, they are essential to provide some 
background to these participants‟ experiences of transplant.  This information places the 
data which has been subject to IPA in context.    
 
The four superordinate themes that emerged from participants‟ accounts were 1) Altered 
QOL, 2) Protected QOL, 3) A new perspective and 4) Changing over time.  The themes 
are presented in a linear fashion however full appreciation of a theme is maximised 
when  interconnections  with  others  are  considered.    The  researcher  has  attempted  to 
provide  quotes  that  reflect  the  individually  considered  themes  however  the 
interconnected nature of the themes means that some individual quotes may reflect more 
than one theme.      
   
Theme 1:    Shifting sense of self and others 
All  participants  described  post-transplant  experiences  which  underpinned  a  sense  of 
alteration to various aspects of QOL and wellbeing including a changed sense of self; 
changed family life; and changed emotional wellbeing.      
Changed sense of self 
Most participants reported that the resultant physical impairments of HSCT meant more 
than just an inability to do some of the things they used to do, but in fact impacted their 
self-concept (literally the way we view ourselves).  Participants talked about living with 
a changed physical identity which in itself was challenging to their view of themselves 
as having been fit and healthy individuals.  This transformed body felt unknown and 
represented a loss of individual identity requiring adjustment:   63 
 
“I went in to the transplant with a physical age maybe ten years younger than, eh, than 
my, sort of, normal age group.  So, I, I think probably, probably one of the biggest 
shocks has been to age ten years in one [laughs].  Eh, cause that kind of takes quite a bit 
of adapting to in itself, y‟know, just, em, so, I, I just have to suddenly I‟m living within 
those kind of [inhales] limit, limits.” [Geoff; L184].   
Recovering from HSCT often meant that family members were involved in caring for 
participants.  David describes the way this experience was particularly difficult for him 
due  to  the  direct  challenge  this  made  to  his  core  beliefs  and  longstanding  view  of 
himself as independent:    
“I:  And what‟s that been like for you – your wife‟s role in your care and supporting 
you?   
P:  Well, I didn‟t find it easy cause I‟ve been pretty independent all my life.  Em, [pause] 
yeah, sort of [slight pause] it‟s been part of my definition of me that I do things, y‟know, 
I do things.  Em, and when you can‟t [laughing] it‟s, well, y‟know, it‟s hard.” [David; 
L582]. 
Physical impairments often meant that at times participants felt unable to do some things 
as well or as effectively as they used to do.  For some participants, this meant that their 
view  of  themselves  was  changed.    Such  changes  in  perception  of  competency  can 
potentially compromise self esteem and disrupt the stable sense of self, as described by 
David:  
“I:  And you were talking about something really important  – the frustration about 
things that you used to do, and the meaning of I‟m wondering, things like being able to 
do the fuel? 
P:  Well, it makes you feel yourself to be less than you were.” [David; L628].   
Although participants described living with various physical health impairments and 
side-effects  as  a  result  of  transplant,  these  were  not  always  appraised  as  being 
necessarily problematic in and of themselves.  When these limitations interfered with 
participants‟ self-understanding, however, difficulties arose.  For Harold, reading had a 64 
 
particular significance due to his lifelong profession and so the loss of his vision was felt 
deeply  as  it  represented  a  loss  of  self.    Physical  impairments  take  on  particular 
significance and meaning when the core sense of self-understanding is threatened and 
this can increase vulnerability to psychological distress at times, as made sense of by 
Harold: 
“But,  what  I  find  particularly  frustrating  is  the  loss  of  my  vision.    Em,  because 
everything I like doing... I can‟t read a book for example, comfortably and I find that 
very frustrating.  Because, that‟s been the basis of my whole life really.   
I:  Yes, yeah.  That must be really hard.  And I‟m just wondering how that affects you 
psychologically? 
P:  Well, it gets me depressed sometimes but I basically feel – the majority of the time, I 
feel, well, this is something I have to deal with and um, make the most of it.  And, I‟m 
generally, have a positive attitude toward life.  Um, as I say, I‟d rather be here than not 
[laughs].” [Harold;  L206].  
Participants  often  described  the  first  year  of  life  after  transplant  as  particularly 
challenging due to reduced physical capacity and having to minimise risk of infection.  
This  level  of  restriction  often  represented  a  significant  change  in  existence  for 
participants and a loss of continuity to life and self-concept.  James described the impact 
this has on his sense of self and the loss of a familiar self.  His use of language conveys 
a sense that this experience of poor health and reduced functioning represents a moving 
away from how he saw himself before transplant and a lack of continuity – the person he 
is today is not the busy, working person he was before transplant:    
“I‟ve had a pretty boring life for the last 10 months sitting at home doing very little and 
for somebody that did you know a pretty responsible job and uh had a very busy life, it 
was a complete turnaround.” [James; L191].  
Changed family life 
Living with ongoing health problems as a result of transplant was perceived as altering 
family  life  by  many  participants.  For  many  it  meant  that  participants  experienced 65 
 
disruption at times to normal family functioning, threatening the stability and continuity 
of the family unit.  
 James  described  the  sense  of  disconnection,  fragmentation  and  change  in  dynamic 
experienced within the family unit.  His description indicates his feeling of separation 
from his family as his health prevents him from participating in family life to the same 
degree.  His language also suggests a sense of burden as the normal family roles are 
altered.  There is a shift in relationship equilibrium as a result of the loss of fitness as his 
wife takes on most of the responsibility of running the family home:  
“Well, you end up eating at different times, you end up uh, um, uh, you know, just, just 
having almost well a completely different way of life really.  You used to sit down and 
eat meals together you‟d do different things that suit each other and the other thing is 
you can‟t, you‟re not fit enough to contribute to running the house so all the pressure 
goes onto your spouse to run the whole of the house and everything from cooking to 
ironing to gardening, to everything and that‟s very much a one way thing.  I‟m just not 
fit enough to do any of it.” [James; L157]. 
For  one  participant,  this  transformation  of  family  functioning  has  the  potential  to 
negatively  influence  relationships  as  families  try  to  adjust  to  the  changed  physical 
capabilities of the individual following transplant.  David makes sense of this process of 
recovery as creating tension in his marital relationship due to his wife‟s anxieties about 
his health and his trying to do more physically:     
“It‟s distanced us a bit I think actually and that‟s basically because we tend to argue 
quite a lot about um, about what I can do and what I can‟t do.  Em, but em, [pause] I 
think that‟s partly cause we‟re both learning.  Both learning what I can and can‟t do 
y‟know, so hopefully that‟ll go away.”  [David; L508].  
However,  positive  effects  on  relationships  were  experienced  by  2  participants  who 
described “feeling closer” to her family [Mary; L355] and Paul described the way since 
his illness he sees “them more now” [736].  In general, however, changes in family 
relationships were not elaborated upon but these comments reflect the paradoxical way 
HSCT can impact family life.        66 
 
Many  participants  described  living  with  a  compromised  immune  system.    The 
consequences of this meant some of those participants‟ normal family life and family 
plans experienced interference.  For example, Paul describes the guilt and frustration he 
feels about being unable to take his family on holiday.  He perceives his compromised 
health status means that his family miss out on normal activities and pleasure: 
“what really gets me is – I‟m no, they‟ll no let me go on holiday.  I cannae leave the 
country, right?  Em, in case obviously I get an infection or anything like that.  And, and, 
[wife‟s name] loves the sun, loves to get a tan em, and she‟s no had a holiday and I feel 
bad about that.” [Paul; L297]. 
Participants described the way this experience of being unable to do things together to 
the same degree could  feel upsetting at times.   Geoff describes the way his  fatigue 
imposes limits on doing things with his wife and that this creates a sense of isolation for 
them both as well as a concern for his wife‟s wellbeing:   
“y‟know, it‟s I, I slip off for an afternoon‟s snooze but that does limit the sort of things 
that we can do together as a couple.  Em, so, that limits her as well y‟know, I can, I‟m 
just living with this, but those limitations have been extended to her as well in some, in 
some ways.  Eh, so y‟know, I‟ve, I, I do try and get her to go off and do things by herself 
here and there y‟know.  But, that can be, it can be lonely eh, if you‟re not doing things 
with your partner and y‟know, we are quite close [inhales].” [Geoff; L327].  
For some, the impact on family functioning was experienced in terms of participants‟ 
ability to maintain their role within the family.  Participants found it challenging to meet 
the needs of other family members at times and maintain previous family roles and 
responsibilities due to reduced physical functioning.  Physical problems per se are not 
necessarily the issue until they interfere with family roles and responsibilities.  Mary 
described  the  way  her  changed  capacities  take  on  particular  significance  when  they 
interfere with her ability to maintain her valued role of caring for her mum.  This results 
in her feeling conflicted and guilty.  She also describes the way her attempts to maintain 
this role jeopardise her own vulnerable health: 67 
 
“I find that quite difficult and really I should be going this weekend and I think – I‟m 
not actually up to it and then who do you put first?  Do I put her first or do I put me 
first?  And I find that difficult whereas, if I hadn‟t been ill I know that I would have 
jumped in the car and gone and it wouldn‟t have been a problem.  I suppose I was quite 
an active person...But I did gradually have to stop doing – I couldn‟t do lots of physical 
things in a day cause I would get tired.  But em, I mean that‟s – it‟s not really a problem 
until I think, “Well, I should be going through and seeing my mum this weekend?  So 
I:  And so, how do you deal with that?  What‟s that like? 
P: ...I brought her back cause I thought that would be easier and twice when I‟ve had 
her to stay for the week – I‟ve ended up at the doctor and got antibiotics the next day.”  
[Mary; L531]. 
Changed emotional wellbeing 
Many participants described their experience of HSCT in controlling their disease meant 
that their emotional wellbeing was enhanced and that participants felt more at “ease”, 
which was thought to be extremely important to their overall sense of QOL.  Despite 
living with uncertainty of disease recurrence, this did not seem to create any persistent, 
detrimental impact on their wellbeing.  Rather, HSCT was described as an emotional 
benchmark or turning point; that they could allow themselves to relax and begin to think 
about  a  future  no  longer  consumed  by  the  fear  and  threat  of  illness  and  possible 
untimely mortality: 
“After the transplant I had total quality of life because it gave me back my health and 
my strength, back even probably better than I had before.  But over and above that, and 
far  more  importantly  for  me,  it  gave  me  hope  that  maybe,  just  maybe,  you  know, 
everything was going to be alright.  That is what was the main sort of quality of life for 
me and the transplant gave me that, it gave me my strength back and it gave me the 
mental hope that everything after all would be fine.  You know, that I had finally closed 
this  horrible  chapter.    Em,  although  there‟s  no  guarantees  but  within  myself  I  felt 
[pause] more, em, how will we say, at peace with myself.” [Helen; L218].   68 
 
They described being “more positive about the future” [Mary; L317] and feeling as 
though the potential risks of transplant were worth it for the sake of having less fear and 
anxiety about the disease recurring.  The persistent anxiety and low mood associated 
with living with fear of relapse prior to HSCT was replaced with an alleviation of such 
worries: 
“I was aware that y‟know, yes I might, I might die going, going through the process but, 
em, it, there, it was a better chance than, than just sticking with the chemotherapy and 
permanently having that sort of black cloud, y‟know, you‟re always looking over your 
shoulder and – is it coming back again?  I think this is, this is a much better situation 
that I‟m in.” [Geoff; L557].     
A new sense of hope and optimism replaced participants‟ prior inability to look towards 
the future with feelings of joy and happiness rather than sadness and grief: 
“The way I see it now  y‟know, I‟m hoping to  be here  to see my grandchildren get 
married and y‟know, graduate.  That type of thing y‟know – I couldn‟t see y‟know, when 
I was ill, I couldn‟t see that.  I couldn‟t see that happening.  But now, the like of that – I 
can see that happening.  Y‟know?” [Isobel; L464].    
For some, the experience of surviving HSCT and life threatening illness had left them 
with an enhanced sense of hopefulness rather than any anxiety and depression about the 
future: 
“I don‟t think I‟m more pessimistic a person or more, if anything, I‟m slightly more 
optimistic [laughs].  I think having been through something like this and come out the 
other end, relatively in one piece.” [Harold; L280].   
Although this was the predominant view held by most participants, one participant did 
describe living with significant emotional distress and fear of recurrence of disease, 
characterised by a feelings of pessimism and anxiety:  
“I get awfully emotional [pause] eh, a, a, and it could, I could be driving the car, I could 
be just sitting watching something on the telly and just burst oot and I... just hits me like 
that – I don‟t know why.  I don‟t know what does it.  Em, I mean, I know like, sometimes 69 
 
with the grandkids… I don‟t know, just y‟know, things that I‟ll miss and that.” And 
later;  
“But, every time I take a cold now, I worry, you know, I think, “Is this going to get 
worse?”  [Paul; L150; L577]. 
This diverging view may be explained by  Paul‟s circumstances.  Paul was the only 
participant  requiring  top-up  lymphocytes  at  the  time  of  interview,  in  order  to  help 
control his disease.  His disease had not relapsed and this process is considered part of 
standard care following the type of transplant received by these participants.     
Theme 2:    Adaptation and managing the impact 
Most participants frequently moved on to describe ways in which the potential negative 
impact to various aspects of their wellbeing is buffered and protected by a number of 
factors.  Participants‟ subjective meaning of the impact was influenced by a number of 
experiences – coping; age and stage of life; and social support.      
Coping 
Despite  the  challenges  experienced  by  participants,  most  described  simultaneously 
finding ways to adapt by using a variety of strategies in order to maintain or improve 
QOL.  As a result, the meaning of the impact on their QOL and wellbeing is mediated 
by their experiences of coping with the challenges.  For example, Harold described the 
importance of using compensatory methods to find meaning and pleasure in life.  He 
also  demonstrates  the  importance  of  attitudes  and  beliefs  in  terms  of  facilitating 
adjustment and adaptation.  He acknowledges the sense of loss felt but rather than this 
meaning that he perceives his wellbeing to be destroyed, his experience of coping by 
finding other ways to enjoy life means that he feels QOL is upheld:   
“the vision is the worst impairment – gives me the most em, it‟s the most disruptive and 
the most depressing – the loss of visual but, um, I can cope with that.   
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P:  Well, I just find other things to do [laughs].  Uh, listen to music more, um, just I 
enjoy, I‟ve always enjoyed just sitting outside em, and if I sit outside I enjoy with my 
eyes  closed  sometimes,  it  doesn‟t  matter  [laughs] if  I  sit  –  I‟m  quite  happy  just  to 
breathe the fresh air and feel the wind in my face – that‟s ok.  And, well, it‟s just life 
really – it just changes – you can‟t hold onto change and I feel quite ok with it.  There‟s 
no point trying to be stuck – life is change and I feel that that‟s the way it is.  I‟m not, I 
don‟t feel uniquely em, eh, or, y‟know, that I‟ve been picked out to suffer.  I think that‟s 
the important thing – I don‟t feel hard done by and if I felt hard done by, that all this 
darkness falls that they didn‟t give me the right sort of care and that‟s why I‟m suffering 
now, I‟d be a bit bitter I suppose.  But, I definitely don‟t feel that.  I think they did the 
best they could – they kept me alive and they cured the things – they‟ve done what they 
could do.  And I‟m very happy with the treatment.  I‟m happy to be here as I say.  I 
accept the consequences that are inevitable and predictable.  And it‟s not a question of 
fair or not fair it‟s just the nature of life.”  [Harold; L365].  
Coping styles varied among participants with attitudes being particularly important in 
mediating  the  perceived  impact  of  the  effects  of  the  transplant  on  QOL.    Geoff 
illustrates the way his proactive coping style and attitude allows him to feel as though 
his QOL is not restricted by his compromised immune system.  Rather than avoiding 
social situations and withdrawing, he feels it important to stay involved in the world 
whilst being sensible about not putting his health at unnecessary risk:  
“Well, you‟ve just got to get a balance really.  You can‟t lock yourself away as a, as a 
hermit thinking “Oh, god, y‟know – it‟s dangerous is that world out there – I might 
catch something”..So, yeah, I‟m living within those limitations but y‟know they‟re not 
too, too onerous  are they?” [Geoff; L529].     
Participants described an incredible ability to cope at all stages of the recovery journey, 
demonstrating strength and resilience even in their most difficult periods.  Participants 
described using strategies to help them hold on to their values in life.  James describes 
the way his goal setting coping style allows him to work towards regaining QOL.  His 
language conveys a sense of agency, control, achievement and hope for the future: 71 
 
“Um, if uh, um, if things continue as they are then and I continue to make progress and 
I can stop having blips like this Graft versus Host Disease and the body starts to settle 
down then I‟ll get quality of life back and I intend to travel again and go round the 
world bird watching and do the things I really want to do.  At least in the UK to start 
with and then um uh abroad again with my friends and family. 
I:  Yeah, so thinking about the future 
P:  Yeah, absolutely, that‟s my target and even just to get down, you know I set small 
targets just to get down the Ayrshire coast for a day out with my friends again uh, is my 
next target, you know for a few hours and have a coffee at a country park and things like 
that, they‟re my targets at the moment.”  [James;  L276].   
Positive  thinking  styles  were  used  by  many  participants  to  help  manage  the 
psychological impact of the ways life had changed, such as living with physical health 
problems; being less active; losing ability to participate in previously enjoyed hobbies; 
and  living  with  uncertainty.    In  this  way,  they  made  sense  of  the  impact  as  being 
experiences to which they could adapt.  Isobel describes the way she feels her coping 
style is important in helping maintain her psychological wellbeing which is potentially 
threatened as a result of her changed abilities.  Her resilience is apparent in the way she 
actively chooses to protect her wellbeing from any negative impact by focusing on the 
here and now rather than ruminating on her losses: 
“I feel that I can‟t do a lot of what I could do before.  Eh, 
I:  And how does that make you feel? 
P:  [pause] Em, och, I never think about it actually [laughs].  I never – actually I don‟t, 
I never think, I never think of what I had before and what I have now because I‟m just, 
I‟ve just gotten to the stage – well, I‟ve just got to accept what, what I‟ve got now.  
Y‟know?  It‟s – there‟s no point in dwelling on what I had before, y‟know what I mean – 
it‟s just what I‟ve got now and I‟ve just got to accept it.  It‟s quite em, y‟know, I think, I 
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that would play on your mind.  You know?  I think it would give you mixed feelings and 
everything.  Mmmhmm.”  [Isobel;  L593].   
Being able to adapt and utilise coping skills helped participants maintain and improve 
many  aspects  of  their  wellbeing  threatened  by  the  experience  of  HSCT  including 
physical, emotional and ability to enjoy life.  Coping allowed them to feel their values in 
life  were  preserved  and  upheld.    Having  the  ability  to  adapt  to  their  challenging 
experiences meant that their sense of competency and agency was maintained.     
An optimistic coping style mediated the potential psychological impact of living with 
uncertainty for a number of participants: 
“I mean, y‟know, ok it‟s there, y‟know ?  It might fall over tomorrow and if that happens 
then obviously I‟ll have to deal with it but y‟know, it isn‟t at the moment so I‟m not 
worrying, I‟m not going  to  worry about  y‟know, I‟m not  going  to  worry about  it.” 
[David; L489].  
Although adaptive coping represented the predominant theme for participants, one man 
described  his  difficulty  with  this  and  described  the  way  he  copes  with  anxiety  and 
uncertainty by avoidance and withdrawal which then has a knock on effect on other 
aspects of his wellbeing such as his relationships with his family and his own mood.  
This example seems to illustrate the relevance of the theme and the way coping mediates 
experience of QOL: 
“I: And you say that you worry and again, I‟m sorry for asking what seem like stupid 
questions but you know, how does that then, how do you notice that impacts you, when 
you‟re worrying like that?  What‟s that experience like? 
P:  I just go quiet.  I tend to keep myself to myself.  I sit up in the room, watch the telly 
or I‟m on the laptop.  Em, dinnae do an awful lot.   
I:  Ok, so you kind of withdraw a bit?  And then what happens then within the family 
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P:  They just leave me to it.  They just leave me to it, until I get out of it [laughs].  Aye, I 
mean, [wife‟sname] knows, she‟ll say, “what‟s wrong with you?”  “nothing, fine”, “no, 
it‟s not” [laughs] She knows but she just leaves me to it.” [Paul; L582].     
Age and stage of life 
Many participants reflected on their age and stage of life when making sense of the 
multiple ways HSCT has impacted their lives.  They described the experience of HSCT 
as occurring within the context of a particular stage of life characterised by change and 
transition.    Participants‟  experience  of  this  appeared  to  facilitate  adjustment  to  and 
acceptance  of  a  changed  existence.    For  many,  this  meant  that  the  impact  to  their 
wellbeing was buffered and threat minimised.  As with coping, the subjective meaning 
of the impact of the HSCT on QOL is mediated by participants‟ experience of being at 
particular stage of life and their associated views.   For example, Harold‟s experience of 
physical decline is normalised and transformed into part of the ageing process which 
seems to allow him to cope with the change and create less biographical disruption to 
his life:       
“Well, I think it‟s, it‟s hard to separate the diminished things I can do uh, from being a 
consequence of the transplant or a consequence of just getting older.  And I know people 
who haven‟t had transplants who are just older, getting old, getting on – experience 
diminished capacity and it‟s hard for them to cope with things the same as it is hard for 
me.    And,  clearly  some  of  the  difficult,  eh,  um,  decline  that  I  experienced  is  a 
consequence, albeit indirect, of the transplant – I don‟t, y‟know, I don‟t, in my mind I 
don‟t say oh, that‟s because of the transplant and I, if I hadn‟t had the transplant that 
was a big mistake, I‟d be better – because I wouldn‟t be better [laughs].  I wouldn‟t be, 
I wouldn‟t be complaining about it, I wouldn‟t be here.  So, I think that, as I say, it‟s, I 
view it as y‟know, that life, eh, is a journey and you go through it and your ability to live 
and do things, changes – it‟s quite different from when you‟re seventy compared to 
when you‟re twenty five.”  [Harold; L334]. 
All participants experienced change in their ability to be involved in previously enjoyed 
activities.    For  some,  age  related  beliefs  and  expectations  buffered  the  potential 74 
 
psychological impact of this loss.  Isobel describes her feelings of loss in response to 
being  no  longer  able  to  enjoy  hill  walking  and  like  Harold,  integrates  this  into  her 
experience of growing older and expected changed abilities.  As a result, emotional 
wellbeing is protected and acceptance and adjustment become possible.  The meaning of 
the loss is thus changed slightly as a result of her views about the ageing process:       
“I:  Yes, mmhmmm.  And you know, I‟m just wondering to what extent you think that life 
or QOL has been what you expected it to be after the transplant?  Has it been what you 
expected? 
P:  Em, [inhales] mmm – well, yes, I think so.  At my age, yes.  I think so.  Em, because I 
was, well, near fifty-five when I went for it.  Em, if I was a younger person, I would 
maybe hope to have more go.  Em, [slight pause] y‟know how, if I was maybe in my 
twenties and thirties y‟know, like, being more physical with, y‟know sports and that – I 
would feel y‟know, that would affect me.  But, now I‟m older – no, I don‟t think so.  The 
only, that‟s the only thing I miss is y‟know – we used to walk a lot y‟know in the country 
and that but I can walk just a wee bit but, y‟know, it‟s just, I just suffer the next day.  
Because I‟m so tired.  See I still get a lot of like, fatigue.  I think that‟s just because of 
the transplant.  But, well   
I:  And how does that affect you? 
P:  Well I don‟t – it doesn‟t affect me so much because I think because I‟m older.  But, I 
think if I was thirty years younger – I think it would affect me. 
I:  Do you think it would be better or worse? 
P:  Em, it would be worse yes.  But what I mean – the fatigue would be worse – y‟know I 
couldn‟t do a lot of things, y‟know?  When you‟re older you don‟t expect to do a lot of 
things.  Am I making sense?  So, y‟know, it‟s not like a big issue to me because I‟m sixty, 
y‟know?  But, well, you just make the best of what you‟ve got at sixty, you know what I 
mean?”  [Isobel; L535]. 
Being of a stage of life where peers increasingly face health problems helped normalise 
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allowed participants to make positive social comparisons to age-similar peers and make 
sense of changed abilities as part of the normal ageing process.  Mary‟s humorous and 
philosophical attitude towards the ageing process helps her feel less different from her 
peers, thereby protecting her view of herself and her abilities:     
“I:  And you mentioned about comparing yourself to your friends who are the same age 
and things – how do you compare yourself to them? 
P:  Em, [pause].  Och, favourably, I – em, em, [pause] I think everybody has their ups 
and downs.  I don‟t feel that – sometimes I don‟t feel that I do as much as some of them 
but then I do more than others so em, it kind of evens out really...I‟ve had a friend who‟s 
had her hip re done and she‟s really struggling, so from that point of view I can get 
about easier than her.  Em, so we‟re getting to that age when we‟re all falling to bits, I 
think [laughs].”  [Mary; L553]. 
For James, the impact of being unable to work as a result of the physical consequences 
of the transplant was buffered by his stage of life.  Such major life changes have the 
potential  to  trigger  serious  biographical  disruption  for  individuals  however  the 
psychological impact of this was buffered by the fact that that this was happening at a 
time in life where such transition was expected: 
“I:  I guess that must have been a big decision though to.. 
P:  It was in a way but I was beginning to think of retiring in a year or so‟s time 
anyway, so it probably wasn‟t as big a decision as it really would have been a couple of 
years ago, um, so I was wanting to go early anyway.  I‟ve worked hard and had a long 
time, so.”  [James; L239]. 
Age and stage of life was also considered to  protect  QOL in terms of reducing the 
pressure for participants and their families, as they coped with the experience of life-
threatening illness and treatment.  Helen describes her belief that being at an older stage 
of life can reduce the burden of the experience due to facing less working life demands 
and  priorities.    She  makes  a  downward  social  comparison  to  younger  people  and 
perceives her stage of life to help reduce the impact on overall wellbeing: 76 
 
“[Husband‟s  name]  retired  at  the  end  of  August,  2004...So,  I  mean,  it  was  just  a 
blessing as well that you know, in a way, that he didn‟t have a full time job, because, 
that would have been a real strain on him and myself...And, you know, youngsters that 
are, they‟re working and you know, with mortgages and things like that to worry about 
and my heart goes out to them because, em, money worries and, and family worries and 
things  like  that  over  and  above  having  to  face  the  sort  if  nightmare  of  the  kind  of 
[pause] cancer thing that people face.  I mean, physically and mentally is bad enough 
without having face you know the other side of it”.  [Helen; L626].    
Paradoxically, a number of participants commented on the way being older was also 
more likely to make physical recovery longer and harder: 
“I would imagine that if you were younger – em, and whatever trauma you go through 
when you‟re younger – you pick up quicker than an older person.”  [Mary; L581] 
The meaning of this was not elaborated upon in the data but seems to reflect complex 
beliefs participants hold when making sense of their experiences, perhaps reflecting the 
inherently contradictory nature of the human condition.  The very factor that protects 
them to some degree has also made them more vulnerable.   
Social support 
All participants shared their view that they valued the support they received from their 
friends, families and others when recovering from HSCT.  Those elaborating on the 
meaning  of  this  described  social  support  as  a  factor  mediating  their  experience  of 
wellbeing  and  QOL.    Although  variation  existed  in  accounts,  social  support  was 
described as protecting various aspects of wellbeing negatively impacted by transplant. 
For example, James articulates the way contact from others helps improve mood.  His 
language also conveys the sense of continuity to self concept and life that such support 
brings.  His sense of isolation is reduced by support and he feels part of a wider, shared 
existence that he has been separated from during his recovery:    
“The other thing that‟s very important I think is um I had a very good network of friends 
and a very good network of work colleagues that um uh kept coming and seeing me you 77 
 
know once I was out of the um uh out of the job and on sick leave um I didn‟t lose touch 
with them, they still kept very much coming around and have done that the whole time 
and I think that‟s been pretty important to get that external contact as well.   
I:  Yes, yeah.  What did that do for you? 
P:  Well it lifts you up definitely does and uh um it‟s good to know you‟ve got that 
network of support.”  [James; L194].   
Social support from others was considered an important means of providing a sense of 
normality  when  life  after  transplant  had  become  focused  on  health  care  issues, 
hospitalisation  and  illness.    Mary  recalled  being  visited  regularly  when  in  hospital 
helped her feel less defined and consumed by her illness and allowed her to reconnect 
with her identity as a mum and a social being:    
“..she was a church visitor and she used to go round and she used to sit and have a chat 
with you..And actually it was really quite nice to  – she had 3 girls as well, funnily 
enough and she would speak about her girls.  But she was really nice and that was nice 
to have somebody totally detached.  
I:  You were saying there was something about that that was good – do you know why it 
made a difference? 
P:  I think it made a difference because she wasn‟t involved in looking after me.  She 
didn‟t know what I had or – she was just someone who came in and had a chat and went 
off again.  And because she was – I don‟t know why it was nice – she just – it was just 
something not to do with your care or family or friends that knew that you were ill.  She 
was just somebody that came in and had a chat.” [Mary; L764].  
In  general,  participants  described  valuing  having  their  family  there  throughout  their 
recovery to help them cope both practically and emotionally.  They felt cared for and 
valued  by  others.    Being  part  of  a  wider  family  network  increased  their  sense  of 
wellbeing, even when they were struggling during recovery.  Paul describes the way 
having his family helps his motivation to keep fighting through the difficult times.  His 
family helps his emotional wellbeing in tough times: 78 
 
“And obviously having eh, [names of family members] and that there – eh, I‟m happy – 
cause it keeps me going.” [Paul; L740].     
Theme 3:  A new perspective on life and living 
Regardless of the stage of recovery, all participants described the way their experiences 
had triggered a shift change in their perspective and represented a significant turning 
point  in  their  life  journey.    This  overarching  theme  is  reflected  by  3  sub-themes; 
personal growth and benefit; changed priorities; and reappraising and accepting.   
Personal growth and benefit  
All participants described ways in which their experiences with illness and transplant 
had triggered a sense of positive growth in their lives.  It is not uncommon for positive 
change to co-exist with distress and this was reflected in the accounts of all participants.  
Although variation existed between participants, they all reported experiencing some 
personal growth or benefit, often in a seemingly paradoxical manner.  
For example, Paul described a history of becoming aggressive when stressed yet living 
with the increased stress of illness has triggered a re-evaluation of his interpersonal style 
which allows him to have better relationships with others:    
“I used to get really angry at things – silly things, y‟know?  Em, and it was just a build 
up of stress.  But, eh, now, well, I, I don‟t feel – although – I might have more stress 
because of the illness it‟s not the same.  I‟ve, I‟m, I‟d sit down and, and, and try to talk 
something through rather than lose the head. 
I:  I wonder what that‟s about, how you make sense of that? 
P:  It‟s just totally different.  I don‟t know, I don‟t know eh, what it is.  Maybe, maybe 
things – life‟s more important, y‟know, eh, em, and, you cannae just keep falling out 
with people [laughs] y‟know?”  [Paul;  L405]. 
Coping  with  the  challenges  of  illness  and  transplant  often  acted  as  a  trigger  for 
participants  to  become  more  appreciative  of  others  and  more  outward  looking.  
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much  worse  experiences  with  transplant.    This  tendency  to  make  downward  social 
comparisons prompted a positive change in perspective and outlook towards others: 
“I think you‟re much more accepting.  I think you‟re less judgemental and em, [pause] 
and I think you just appreciate em, what some people – you know I hate coming in here 
– em, what some people have to put up with and go through.  Em, [pause]” [Mary; 
L496].   
Most participants reported being more appreciative of being alive and often described 
having been given a “second chance at life”.  For one participant, the experience of 
surviving her illness and transplant and her belief that she “floated through transplant” 
(Helen; L722] meant that she experienced a profound sense of spiritual growth: 
              “before I was diagnosed away back in 2004, I had never given any kind of thought to – I 
didn‟t go to church, maybe I did when I was young, but I‟d never given any thought to 
the spiritual or religious part of life really...Because, one thing I‟m sure of is, there‟s 
more things that science can‟t explain just as many as things that can explain and em, 
there are miracles out there.  There are miracles out there, I believe that.  So there you 
go [laughs].” [Helen; L668].   
Changed priorities - A time for re-evaluation & reconstitution 
Many  participants  described  the  way  their  experiences  of  illness  and  transplant  had 
influenced a changed view of QOL priorities.  They described re-evaluating aspects of 
their definition of QOL following HSCT.  Participants‟ previously held goals in terms of 
QOL were reconsidered and a new way of life was felt more worthwhile.  This re-
prioritising often reflected hopefulness felt by participants, that new or more meaningful 
experiences in life could be had in the present.  Changed goals seemed to reflect a focus 
on achieving emotionally gratifying experiences.   
The experience of spending long periods in hospital was often described by participants 
as difficult and was one of the reasons for Mary‟s change in priorities, from travel to 
spending time with her family.  Her language also conveys her sense of the way her 80 
 
goals have become present focused and that she has a new appreciation for the joy of 
daily life experiences: 
“I used to think that I would travel quite a lot – I don‟t now.  Eh, funnily enough.  I‟m 
quite happy to be at home.  I think it‟s because you spend so much time away from 
home, em, and from the grandchildren – em [pause] I‟ve got no huge ambitions to do 
anything.  Em, I sew – I still do embroidery and things like that.  Em, so I‟m still hoping 
to do a masterpiece but eh, everyday life – it‟s fine.”  [Mary; L292] 
Changed priorities seemed to be reflective of a turning point in participants‟ lives.  They 
described that having been through the experience of illness and transplant, they now 
wanted to reclaim QOL and define it on their own terms.  This is apparent in James‟s 
reappraisal of the value he placed on work and his decision to retire.  His focus on career 
planning and achievement has shifted and his language suggests a desire to pursue more 
emotionally gratifying activities: 
“I put far too much over the years in [pause] personally into work really.  I worked 
really long hours and um was a pretty committed person to the job I did here, so... I:  
Right.  P:  Um and uh I think uh I don‟t know whether that‟s a contributory factor to my 
illness or not but the amount of time I put in but it probably is not healthy so, to put that 
amount of time into your work... I‟ve decided to take early retirement and I‟m retiring in 
the next month or two and um going to try and get some quality of life back and uh, 
there‟s a lot more to life than working. [laughs]” [James; L86].  
Some participants described wanting to give something back to society as a result of 
having survived HSCT.  They often talked about feeling grateful that their transplant 
had given them a second chance at life.  Geoff describes the way this prompted a new 
sense  of  priority  to  use  his  time  more  meaningfully.    His  language  suggests  he  is 
redefining how he would like to spend his time which involves looking beyond himself 
towards a desire to contribute to society.  This re-evaluation of the important aspects of 
QOL reflects feelings of optimism and positivity: 
“I mean there is one aspect of all this, y‟know, I feel, it has made me think, well, I‟m, 
y‟know, all these people have put all this into me, I‟ve, I‟ve really got to put something 81 
 
back into society – I really owe society something, y‟know, I can‟t just sort of sit back on 
this.  Em, society has given my life back for a reason...I do feel that I shouldn‟t be 
wasting what time I‟ve been given eh, eh, to eh, left on this earth really and I need to be 
doing something positive with it.  So, I y‟know, I‟ve got that in the back of my mind.  
Don‟t just sort of twiddle your thumbs [participant‟s name], you‟ve got to be, got to be 
doing something.”  [Geoff; L447].  
Reappraising and accepting – the losses are worth it 
Many participants described reappraising their losses and challenges.  All participants 
described their physical health as transformed following HSCT.  7 participants described 
experiencing significant ongoing health problems as a direct or indirect result of the 
treatment.  However, they also described being in the paradoxical situation of having 
experienced  improvement  in  their  physical  health  as  a  result  of  the  success  of  the 
transplant  in  controlling  the  original  life-threatening  disease.    This  is  perhaps  best 
captured by Geoff‟s statement: 
“The immune system is ineffective but at least the haemoglobin levels have recovered, 
so that‟s brilliant, y‟know?” [Geoff; L196].   
Despite life after transplant being challenging and disruptive to aspects of QOL, most 
participants  shared  their  view  that  the  losses  are  compensated  by  the  gains.    They 
acknowledge the losses but reconsider them as worth experiencing for the chance of 
being  alive.    Many  described  the  way  they  felt  accepting  of  a  reduced  level  of 
functioning and an ability to cope with disruption for the sake of having a future.  Mary 
describes the way she had to cancel social plans due to poor health but the meaning of 
this  is  mediated  by  her  view  that  she  now  has  a  future  life,  which  is  much  more 
important: 
“So, regardless of missing – you know there were quite a few things this winter that I 
had to cancel – em, which was disappointing, but you know, at the end of the day, you 
know, there‟s still tomorrow.” [Mary; L283]. 82 
 
Although this was the predominant view shared by participants, one participant was 
struggling to reconcile the losses and felt his overall QOL to be inferior to pre-transplant 
life.   
“P:  Yeah, I mean I worked right up – in fact – I even done the Glasgow to Edinburgh 
cycle.  Just eh, in the September before I came in for my bone marrow.  Did that in the 
September and I came in in the October.  Aye, so I was still out and about.  Up until I 
came in.  It‟s only been post the bone marrow that I‟ve – I don‟t really go out – I don‟t 
socialise  much at all.   So, aye, things  have, things  have  changed.   I  wouldnae say 
anything‟s changed for the better.  To be honest, because, physically – I‟m worse.  Eh, 
mentally, probably – so I don‟t and I don‟t, I don‟t really do anything [quieter] don‟t go 
out much.” [Paul; L772].   
Again given the unique situation Paul experienced in terms of the increased uncertainty 
associated with requiring lymphocytes to maintain control of the disease, this may help 
contextualise his diverging view.  Indeed, when considering some of Paul‟s examples 
within other themes, a story emerges for this man which highlights the importance of the 
treating each individual HSCT recipient as a unique person and that one IPA narrative 
account cannot possibly fit the experiences of all.   
Theme 4: Changing over time  
Many participants described the impact on their QOL as changing over time in terms of 
the quality of their relationships with others; physical abilities; emotional wellbeing.   
Mary described the way the sense of self is restored over time and how remission brings 
a resumption of normality.  She describes the way time brings a restoration of the self:  
“I think after a wee while, your relationship kind of goes back – with all of them I think 
goes back to what it was like before.  I don‟t know if it‟s had a huge – I think they all 
knew that em, you know, hoped that everything would go ok.  And then I think because it 
has – they then go back to you know – it‟s same old mum again.   
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P:  I don‟t know.  I suppose because as each day goes on – the transplant, the hospital 
business is further away.  It‟s time.  And it‟s funny – one of the girls that was in when we 
were in the [hospital] [info omitted] and she was on the phone and she said, “isn‟t it 
funny, I‟m feeling really grumpy and I‟m annoyed about this – really it‟s ridiculous – 
same old person”, she said “you forget how”.  I suppose you do lose that, “Oh, I‟m in 
remission”.  Em, and you get back into normal life again.  I think you have to.”  [Mary; 
L376]. 
Participants  often  recalled  being  extremely  unwell  immediately  after  transplant  and 
reflected  on  how  far  they  had  come  since  then  in  terms  of  physical  and  emotional 
wellbeing.  For example, Isobel reflects on being at her lowest in her early recovery 
period and feeling as though she was facing the prospect of death; however, she now 
feels this is a distant memory: 
“after my transplant and that, when I was feeling really ill and down and that – you 
know, I said to my husband, look – I need to write letters and that...em, I just felt that 
[slight pause] I didn‟t say enough, y‟know, before.  So, y‟know, I‟d done all that on 
paper  and  that  but  [tails  off].    But  now,  it‟s  just  –  it  seems  a  pinch  of  salt  now 
[laughs].” [Isobel; L266].   
Physical health and ability to do things and feel positive was also described as changing 
over time.  In this way, QOL is described by participants as a dynamic experience.  
David describes the way the experience of change in itself helps protect wellbeing by 
increasing positivity: 
“And, y‟know, I‟ve been able to get back to doing some things already so y‟know, it‟s 
eh, I‟m really quite positive about it.”  [David; L466].   
The  results  have  attempted  to  capture  the  dominant  stories  and  experiences  of  the 
participants  as  a  collective  group,  whilst  striving  to  retain  each  individual‟s  unique 
journey.  Clearly a tension exists in this process and it is recognised that no one account 
will  fully  represent  the  full  spectrum  of  each  participant‟s  experiences.    Life  after 
transplant seems to be full of inherent contradictions.  However, it seems testament to 
participants‟  resilience  that  they  find  ways  to  reconcile  their  losses  and  adapt  to  a 84 
 
changed existence.  This is not to underplay the significance of the challenges however 
and it is essential for transplant recipients to have access to supports when needed in 
order to help reinforce their resilience when required.      
Perhaps the seemingly paradoxical nature of the results and the journey experienced by 
many participants is best made sense of by Harold:   
“It‟s clearly been a mixed bag of emotions and experiences – it‟s not all horrible, it‟s 
not been y‟know, all wonderful.  And it hasn‟t been easy but uh, I‟m happy I did it – I 
would have been happier if certain things hadn‟t happened like if my eyesight hadn‟t 
been  affected.    Em,  but  that‟s  just  the  way  it  is.    There‟s  no  point  in  me  –  what 
alternative is there?  I can‟t go back and change things so the question is just to move 
forward and um, decide how you‟re going to cope with the situation as you find it.” 
[Harold; L468].   
Discussion  
 
The purpose of the study was to explore recipients‟ experiences of life after HSCT and 
how they make sense of the impact on their QOL.  Four emergent superordinate themes 
were identified.   
The first theme „Shifting sense of self and others‟ reflected the way QOL is impacted in 
multiple  ways  following  HSCT,  consistent  with  a  biopsychosocial  definition  of  the 
construct.  The subordinate theme „altered sense of self‟ was reflective of participants‟ 
perceived change between their pre and post transplant self-concept.  HSCT literature 
reviews refer to this as role functioning, that is, the way individuals define themselves in 
relation to their roles within family and community.  It has been suggested that such 
decreases are transient as individuals resume prior roles over time [26].  However the 
theme as it emerged in this study seemed to reflect a more profound impact on identity 
and former self-image which is a topic less focused upon within the HSCT literature.  
To the researcher‟s knowledge, only one quantitative study has investigated this aspect 
and found that self-concept becomes increasingly defined as a „HSCT patient‟ as cancer 
and its treatment impose increasing lifestyle disruptions [27].  Participants in the current 85 
 
study described that the extent to which they were resuming pre-transplant roles varied. 
Therefore, it may be interesting to explore the impact of HSCT on identity and how 
individuals experience and negotiate any loss of self, as conducted by Kathy Charmaz 
[28] among individuals with chronic illness.   
In terms of „altered family life‟, the study revealed both differences and commonalities 
in  perceptions  of  the  impact  on  family  life  when  compared  to  the  only  other  IPA 
literature on younger recipients [10].  Whereas older recipients discussed a disruption to 
normal family functioning and their ability to do things together, younger recipients 
described their primary fears as being related to not being able to have children and 
develop close relationships [10].  However, younger recipients also reflected similar 
family concerns about their ability to take care of their family and their sense of having 
“no life together” [10 p. 110].  As with the Holmes [10] study with younger adults, 
mixed findings were reported in terms of the impact on relationships with positive and 
negative changes reported (p110).  Within this study, the theme „altered family life‟ 
emerged where participants‟ expressed views that their illness placed demands on their 
family members.  This sometimes led to a sense of isolation and distance as well as 
tension at times as families tried to adjust post-transplant.  Their accounts reflected a 
sense of concern over family well-being which has been documented as a source of 
stress for HSCT recipients [29].  Only one intervention study has been conducted to date 
with both the patient and their care-giver/family member to address their shared distress 
using a problem solving education intervention [30].  Results showed that participants 
found  the  intervention  beneficial  as  it  gave  them  the  “opportunity  to  talk”  and  use 
“creative thinking” to help negotiate the challenges of adapting to the early recovery 
period following allogeneic HSCT (p.24).  Although this theme is not new in terms of 
our  understanding  of  how  life  is  impacted  after  HSCT,  given  the  predominant 
experiences of disruption to family life and participants‟ roles within that changed unit, 
it seems essential that efforts are directed towards working with both recipients and their 
families to help them adjust to any changes, transient or ongoing.  This altered family 
existence also  overlaps  with  the altered sense of self  which helps  us  appreciate the 
importance of the interconnected nature of these themes.   
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The sub theme „changed emotional wellbeing‟ reflected the way participants reported an 
improvement  in  their  mental  wellbeing  following  transplant.    Although  one  or  two 
participants recalled their emotional health being jeopardised when their physical health 
was at its most vulnerable in the early recovery period, this resolved with improved 
health.  No significant or persistent emotional experiences were reported by participants 
at the time of interview with the exception of one participant, who notably disclosed a 
history of mental health difficulties.  These findings are in line with a recent systematic 
review by Mosher et al. [4], who found that HSCT survivors generally report decreased 
distress over time, with most research indicating that mean levels of distress are within 
normative  limits  at  3  or  more  years  post-transplant.    This  finding  is  interesting 
considering the previous subthemes within this overarching „Altered QOL‟ theme which 
highlighted potential threats to emotional wellbeing.  However, when considered in light 
of the other superordinate themes emerging, it may be that these act as „buffers‟ to the 
onset of perhaps of negative emotional wellbeing and boost resilience.  Nonetheless, the 
experience  of  one  participant  highlights  the  importance  of  both  assessing  individual 
emotional wellbeing, and the having psychological services available to help meet the 
needs of recipients.  
 
The  second  superordinate  theme  „Adaptation  and  managing  the  impact‟  reflected 
participants‟ views and experiences of their QOL as being protected in some form or 
another.  Participants showed a remarkable ability to use a variety of coping skills to 
help  preserve  their  sense  of  wellbeing.    Their  accounts  reflected  a  sense  of 
determination,  positivity  and  strength  to  overcome  the  challenges  facing  them  post-
transplant.  This is important as lower levels of anxious preoccupation and higher levels 
of  fighting  spirit  may  be  associated  with  longer  survival  post  transplant  [31].    The 
findings in relation to participants‟ ability to cope and the mediating impact this had on 
their appraisal of QOL also seems to provide support for Lazarus & Folkman‟s [32] 
Transactional  Model  and  suggests  that  facilitating  coping  among  HSCT  recipients 
should  remain  a  priority  for  professionals  supporting  recipients.    Participants  all 
described valuing „social support‟ with many describing the way it helped maintain their 
wellbeing, which would seem to add further support for the findings in the evidence 87 
 
base suggesting that poorer QOL is associated with reduced levels of social support [3].  
The findings also suggest that assessing levels and quality of social support prior to 
HSCT would help identify individuals at increased risk for adjustment problems.     
 
Whilst coping style and social support have both been found to be important predictors 
of QOL and survival post transplant, „age and stage of life‟ is a new emergent theme to 
this area as having a potential buffering effect on QOL.  Previous research found older 
age as predictive of poorer post-HSCT QOL [3, 1].  However, the findings from this 
study suggest adults aged 50 years or more at time of transplant manage the challenges 
of HSCT extremely well and that their older stage of life actually facilitates adjustment 
and coping to maintain their QOL.  There are many psychosocial and developmental 
theories of ageing which are likely to help contextualise the experiences of older HSCT 
recipients and their adaptation to post-transplant life however a full discussion of these 
is beyond the scope of this thesis.  However, participants‟ descriptions of their stage of 
life and utilisation of coping strategies seem to fit well with theories such as Baltes & 
Baltes [33] theory of Selection, Optimisation and Compensation.  This theory helps 
explain successful adaptation to the challenges of ageing which could also be applied to 
the  older  HSCT  recipients  facing  the  challenges  of  reduced  physical  functioning.  
Indeed,  many  participants  seem  to  be  naturally  utilising  such  approaches  by  de-
prioritising certain skills and tasks and selecting new ones that give their lives meaning.  
Their descriptions of using coping to hold onto valued goals also seems to fit with 
Ouwehand et al.‟s [34] theory of proactive coping.  Overall, given the findings relating 
to  „age  and  stage  of  life‟  and  the  interconnected  theme  of  „coping‟,  it  seems  that 
research  pertaining  to  theories  of  successful  adaptation  to  ageing  may  be  a  useful 
framework to consider when helping older HSCT recipients adapt but also as a useful 
additional conceptualisation for further research with older HSCT recipients.   
          
The findings from the third superordinate theme, „A new perspective on life and living‟ 
reflect issues that have been identified in the wider HSCT literature and add strength to 
some of the more preliminary findings.  The findings from these 3 sub-themes generally 
reflect a focus on positive changes in quality of life after HSCT.  Participants on the 88 
 
whole described the way their experiences of surviving illness and HSCT had triggered 
„personal growth‟ and „changed priorities‟ in their lives.  They describe reinterpreting 
surviving the trauma of illness and HSCT as an opportunity for growth and benefit 
finding.    They  also  describe  their  acknowledgement  that  some  goals  are  no  longer 
attainable and begin to formulate new goals.  A number of current theories exist to help 
explain this apparent paradox following the experience of traumas including serious 
illness  [35].   HSCT  literature  refers  to  this  positive  psychological  and  interpersonal 
growth  as  described  by  participants  in  this  study  as  “post-traumatic  growth” 
(Andrykowski  et  al.  1993)  [36].    The  findings  of  this  study  support  this 
conceptualisation of HSCT as a “transitional event which creates the potential for both 
positive and negative change” [36, p. 261].  The experiences described by participants 
fit with Wingard & Bishop‟s [8] contention that in order to develop a comprehensive 
understanding of post HSCT QOL, both losses and gains should continue to be assessed 
(p.115).    
 
In terms of the final sub-theme, ‘Reappraising and accepting – the losses are worth it‟, 
participants‟ described that despite facing significant losses and challenges, they seemed 
to take a philosophical view that their life was still good and worthwhile.  The previous 
themes of coping, social support, and stage of life as well as the aforementioned theories 
of  adaptation  may  well  account  for  the  mechanisms  facilitating  adjustment  in  a 
paradoxical situation.  However, a recent theoretical response shift model developed by 
Sprangers & Schwartz [37] was first utilised with a HSCT population in a qualitative 
study and found evidence of recipients engaging in response shifts such as lowering 
standards  for  what  constitutes  “good”  QOL  [38].    This  theory  would  also  fit  with 
participants‟  accounts  in  this  study  as  reported  in  this  sub-theme.    Overall,  this 
superordinate theme seems to reflect adaptation and adjustment that could be explained 
by a number of relevant theories.  Regardless of the mechanism used participants are 
describing their incredible ability to adjust. 
 
This  final  superordinate  theme  ‘Changing  over  time‟  is  not  new  in  terms  of  HSCT 
research literature and conceptualisations of QOL as a dynamic construct. The majority 89 
 
of participants report positive change over time.  It supports recent empirical evidence 
summarised in reviews regarding overall QOL after allogeneic HSCT as characterised 
by  ongoing  improvements  reported  from  6  months  to  4  years  post-transplant;  and 
continued long term impairment relative to non-cancer comparison groups [26 p, 374].  
This  quantitative  evidence  is  valuable  to  patients  facing  the  decision  to  undergo 
transplant.  However, this study highlights some of the mechanisms which might help 
explain such quantitative findings as a result of examining the experience in-depth.  The 
4  interconnected  themes  demonstrate  the  challenges  facing  recipients  and  also  the 
interconnected processes of adaptation.    
   
Conclusions  
 
Overall, findings suggest that the sample of recipients who participated in this study are 
adjusting well to the challenges that this procedure presents.  Many commonalities in 
experiences have been documented in the current literature relating to post allogeneic 
HSCT in younger patients.  Participants describe living with various chronic symptoms 
and  given  their  increased  age  these  can  be  more  difficult  to  manage.    However, 
paradoxically  they  are  simultaneously  protected  from  this  by  various  „stage  of  life‟ 
factors and an increased acceptance of changing abilities.  Chronological age has not 
been found to be an independent factor in psychological adaptation post HSCT in this 
study.  This is a much more nuanced variable which is impacted and mediated by a 
number  of  important  individual  and  interpersonal  factors.    Participants  have 
demonstrated that they have the capacity to cope with the challenges of treatment and its 
resultant side-effects and value the treatment hugely.  These individuals are adapting 
and reconstructing their QOL priorities to lead meaningful lives and have a desire to 
make valuable contributions to society.  However, this population is characteristically 
heterogeneous, therefore pre-transplant assessment of variables such as coping style and 
social support seem crucial to consider with individuals and partners in order to help 
best  discuss  informed  consent  and  ensure  that  support  is  delivered  and  targeted 
effectively.    The  remarkable  adaptation  described  by  participants  should  not  deflect 
attention  from  the  very  significant  physical  and  psychological  challenges  facing 90 
 
recipients as they negotiate their way through recovery.  Hopefully, the findings of this 
study  provide  some  unique  insights  into  the  experience  of  older  adults‟  QOL  after 
allogeneic  HSCT  that  have  important  ramifications  for  their  decision  to  undergo 
transplant and their adjustment to life after transplant.   
 
Implications for Clinical Practice 
Recipients‟  adjustment  to  life  following  HSCT  could  be  facilitated  through  the 
application of research which has examined factors associated with successful ageing 
and adaptation to stressors.  Psychologists, as part of a multidisciplinary team, have an 
important role to play in terms of their skills in formulating difficulties and developing 
strategies,  in  conjunction  with  the  patient,  to  compensate  for  losses  and  bolstering 
resilience or „post-traumatic growth‟.  Patients may also be helped to maximise their 
coping skills  and peer support,  possibly via haemato-oncology support groups.   For 
patients requiring specific psychological intervention, Cognitive Behaviour Therapy and 
Acceptance and Commitment Therapy may be of value in helping recipients in recovery 
move forward in the context of change whilst holding onto their values in life.  These 
psychological models may be particularly useful then for HSCT recipients requiring 
psychological intervention.  In addition, it is important that interventions and support are 
offered to families and partners, where indicated. 
When using standardised questionnaires, as part of QOL assessment, it is important to 
elaborate on responses by asking recipients how they are coping with change.  It is also 
important to continue to conduct pre-assessments of coping styles, social support and 
psychological  histories  in  order  to  identify  individuals  who  are  at  increased  risk  of 
developing psychological difficulties and ensure that appropriate psychosocial supports 
are available.  In addition, the use of ongoing assessment, for example, at yearly late 
effects clinic appointments would be helpful in monitoring patients‟ changing needs. 
It is also important to continue to inform potential recipients of the possible changes to 
life  that  may  be  experienced  (positive  and  negative)  following  transplant  and  help 
recipients feel as included in the process as possible.  This could be done through the 91 
 
provision of information, signposting to relevant services, and facilitating contact with 
other transplant recipients.  Finally, the findings from this research could form the basis 
for  specific  information  provision  for  older  patients  considering  RIC  HSCT  (e.g. 
through a leaflet) outlining what strategies other patients have reported facilitated the 
adjustment process.   
Implications for Future Research  
It would be useful to conduct further qualitative studies with homogenised groups in 
order to assess particular aspects of the experience of HSCT, for example, the impact of 
HSCT on identity and self-concept.  This would allow a more in-depth exploration of 
how individuals restore their sense of self following major medical interventions such as 
HSCT. 
Future research should focus on adaptation studies to identify holistic care needs.   In 
addition, more studies are needed to assess the impact on carers and their QOL post-
transplant. 
Finally, more quantitative studies and longitudinal research designs are needed in order 
to  assess  the  importance  of  predictors  of  quality  of  life,  such  as  coping  styles.  
Correlation  study  designs  would  likely  add  to  our  understanding  of  links  between 
coping, support, age etc.  
Limitations of Study 
There are a number of limitations that must be taken into account when considering the 
conclusions and suggested implications of this study.  Firstly, the participants were all at 
various stages of recovery and therefore QOL concerns will reflect these stages.  It 
could  be  that  those  participants  with  longer  duration  post-transplant  will  naturally 
demonstrate  increased  adjustment  however  the  findings  suggest  that  this  process  of 
adaptation and adjustment is evident even in those most recently transplanted. 
Since QOL is a dynamic and changing construct, homogeneity is reduced which is an 
important  factor  in  IPA  studies.    However,  homogeneity  was  considered  in  the 92 
 
development of the study and is reflected in the sample of participants who all received 
the same type of RIC HSCT from an unrelated donor. 
Another issue to consider is the fact that the participants in this study all chose to take 
part and their disease had not relapsed.  Undoubtedly, the QOL experiences of recipients 
for whom disease had not been successfully controlled post-transplant would be very 
different.   
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ABSTRACT 
 
The  British  Psychological  Society  requires  that  clinical  psychologists  be  trained  as 
competent  reflective  scientist-practitioners.    Engaging  in  reflective  practice  allows 
clinical psychology trainees to critically appraise individual professional development in 
a  constructive  manner.    Training  placements  provide  environments  full  of  learning 
experiences  and  opportunities  however  it  can  be  challenging  to  incorporate  those 
experiences into a meaningful and coherent narrative that is reflective of how we have 
progressed  as  trainees.    The  reflective  account  that  follows  therefore  represents  an 
attempt to articulate my understanding of how I have grown as a clinician as well as the 
limits of my competences as they currently stand.  The account will use Rolfe et al.‟s 
(2001) educational model to structure the reflexive process.  It will also draw on other 
relevant psychological theories to deepen the reflection.  This reflective account will 
consider the context of National Occupational Standards for Psychology to help link 
experiences to my perception of my clinical skills and competences.  The account will 
focus  on  the  experience  of  working  with  complex  cases  in  a  specialised 
multidisciplinary team. 
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ABSTRACT 
The National Occupational Standards for Psychology (NOS) help define the areas of 
expertise and common competencies associated with the roles of Clinical Psychologists.  
This reflective account focuses on Generic Key Role 6, defined as management of the 
provision of psychological systems, services and resources.  The decision to focus on 
this role stemmed from an awareness of the current political and professional climate of 
change and an uncertainty as to the role of clinical psychologists within this context.   
Rolfe, Freshwater and Jasper‟s (2001) Framework for Reflexive Practice, is used to 
provide  structure  to  the  reflective  piece.    The  account  attempts  to  demonstrate  the 
strengths and limitations of my competencies as a clinical psychologist in training and 
the  learning  experiences  that  have  shaped  my  understanding  of  my  professional 
development.  In addition, the regulatory body for clinical psychologists, the Health 
Professions  Council,  highlights  that  clinical  psychologists  must  be  able  to  use  a 
reflective practitioner model when working with clients and so this piece of work is also 
an effort to demonstrate this required competency.          
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Appendix 1.1: Bone Marrow Transplantation Guide to Authors   
 
 
For further details access   
http://mts-bmt.nature.com/cgi-bin/main.plex?form_type=display_auth_instructions 103 
 
Appendix 1.2: Quality Rating Form 
QUALITY CRITERIA ASSESSMENT DATA COLLECTION SHEET 
 
Study ID (Author, title, year of publication, journal title, pages):  
 
 
 
Study Design: 
 
Checklist completed by: 
 
SECTION 1: RATIONALE 
 
1.1  
 
The study addresses an appropriate and clearly focussed 
question. 
 
1 Yes                     
0 No    
              
 
1.2 
 
Are the main objectives clearly stated?  1 Yes 
0 No 
TOTAL: SECTION 1                                                                                                                             /2 
SELECTION 2: PARTICIPANTS 
 
2.1  Participants are recruited in a scientifically appropriate 
manner and are representative of the defined population 
2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
2.2  The study has a control group  1 Yes 
0 No 
2.3  The assignment of participants to treatment groups are 
randomised  
1 Yes  
0 No 
2.4   An adequate concealment method is used?  2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
2.5  The treatment and control groups are similar at the start 
of the trial 
2 Well Covered 
1 Adequately addressed 
0 Poorly addressed / Not 
Applicable 
2.6 
 
Are any inclusion/exclusion criteria stated?     1 Yes 
0 No 104 
 
2.7  Is the sample size stated?  1 Yes 
0 No/not stated 
2.8  The only difference between groups is the treatment 
under investigation 
2 Well covered 
1 Adequately covered 
0 Poorly addressed/ Not 
Applicable 
 
 
2.9   All relevant outcomes are measured in a standard, valid 
and reliable way for use with the sample population 
2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
2.10  Are intention to treat analysis carried out? (All subject 
data randomly allocated to group is analysed) 
2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
TOTAL SECTION 2:                                                                                                                           /16 
SECTION 3 CONFOUNDING FACTORS: 
3.1  The main potential confounders are identified and taken 
into account in the design and analysis where appropriate 
2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
TOTAL SECTION 3:                                                                                                                              /2 
SECTION 4 STATISTICAL ANALYSIS 
4.1  Is the analysis appropriate to the design and type of 
outcome measure? 
1 Yes 
0 No/not stated 
4.2  Are the results clearly reported?  2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
4.3  Have confidence intervals, effect sizes, p-values etc been 
provided where appropriate? 
2 Well covered 
1 Adequately covered 
0 Poorly addressed 
 
TOTAL SECTION 4:                                                                                                                              /5 
Quality scores 
 
OVERALL TOTAL:  ____/25 
 
PERCENTAGE:    ____%  
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QUALITY RATING: ____________________ 
Poor (<50%), Moderate (50-74%), Good (>75%) 
 
 
 
 
 
 
DESCRIPTION OF STUDY  
 
 
 
 
 
 
 
How many patients are included in this study? 
List the number in each group separately  
 
 
 
 
What are the main characteristics of the study 
population? 
Include all relevant characteristics – e.g. age, sex, 
disease status, community/hospital based 
 
 
 
 
 
What environmental or prognostic factor is being 
investigated in this study? 
 
RCT - What intervention (treatment, procedure) is 
being investigated in this study? 
 
 
 
 
 
What comparisons are made in the study? 
 
Are comparisons made between treatments, or 
between treatment and placebo/no treatment  
 
 
 
 
For how long are patients followed-up in the study?   
 
Length of time participants are followed from 
beginning participation in study.  Note specified end-
points used to decide end of follow-up  
 
 
 
 
 
What outcome measures are used in the study?  
List all outcomes that are used to assess the impact 
of the chosen environmental or prognostic factor 
 
List all outcomes used to assess effectiveness of 
interventions used. 
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What size of effect is identified in the study? 
List all measures of effect in the units used in the 
study- e.g. absolute or relative risk.  Include p-values 
and any confidence intervals that are provided.  
Note: be sure to include any adjustments made for 
confounding factors, differences in prevalence, etc.   
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Appendix 1.3:  Excluded papers following inclusion/exclusion criteria  
EXCLUDED PAPERS – n = 28  
Review/Editorial/Commentary papers  
Liu  RDKS,  Chinapaw  MJM,  Huijgens  PC  van  Mechelen  W.  Physical  exercise 
interventions in haematological cancer patients, feasible to conduct but effectiveness to 
be established: A systematic literature review. Cancer Treat Rev 2009; 35: 185-192. 
Shennan C, Payne S, Fenlon D. What is the evidence for the use of mindfulness-based 
interventions in cancer care? A review. Psychooncology 2011; 20: 681-697.  
Schulz KH. A comprehensive coping strategy programme reduced nausea and fatigue 
after autologous bone marrow transplantation for breast cancer. A commentary. Evid 
Based Mental Health 2001; 4: 14-15.  
Somerfield, MR, Rizzo, JD. Can a modest exercise program really improve physical 
functioning and quality of life among recipients of hematopoietic SCT? Bone Marrow 
Transplantation 2010; 45: 217-218. 
Wiskemann  J,  Huber,  G.  Physical  exercise  as  adjuvant  for  patients  undergoing 
hematopoietic stem cell transplantation. Bone Marrow Transplantation 2008; 41: 321–
329. 
Children/adolescent/young adult mixed sample age group 
Burns DS, Robb SL, Haase JE. Exploring the feasibility of a therapeutic music video 
intervention in adolescents and young adults during stem-cell transplantation. Cancer 
Nurs 2009; 32: 8-16. 
Non Haematopoietic SCT participant group 
Duijts SFA, Faber MM, Oldenberg HSA, Van Beurden M Aaronson NK. Effectiveness 
of behavioral  techniques and physical exercise on psychosocial functioning and health-
related  quality  of  life  in  breast  cancer  patients  and  survivors  –  a  meta  analysis. 
Psychooncology 2011; 20: 115-126. 108 
 
Luebbert  K,  Dahme  B,  Hasenbring  M.  The  effectiveness  of  relaxation  training  in 
reducing  treatment-  related  symptoms  and  improving  emotional  adjustment  in  acute 
non-surgical cancer treatment: A meta-analytic review. Psychooncology 2001; 10: 490– 
502. 
No psychosocial or Quality of Life outcome measures reported 
Gabriel B, Bromberg E, Vandenbovenkamp J, Walka P, Kornblith AB, Luzzatto P. Art 
therapy  with  adult  bone  marrow  transplant  patients  in  isolation:  A  pilot  study. 
Psychooncology 2001; 10: 114-123. 
Jarden M, Nelausen K, Hovgarrd D, Boesen E, Adamsen L. The effect of a multimodal 
intervention on treatment-related symptoms in patients undergoing hematopoietic stem 
cell transplantation:A randomized controlled trial. J Pain and Symptom Manage 2009; 
38: 174-190.  
Kim, SD, Kim HE. Effects of relaxation breathing exercise on fatigue in haemopoietic 
stem cell transplantation patients. J Clin Nurs 2005; 14: 51-55. 
Sahler OJ, Hunter BC, Liesveld JL. The effect of using music therapy with relaxation 
imagery in the management of patients undergoing bone marrow transplantation: a pilot 
feasibility study. Altern Ther Med 2003; 9: 70-74. 
Not an intervention based study 
Courneya  KS,  Keats  MR,  Turner  R.  Physical  exercise  and  quality  of  life  in  cancer 
patients  following  high  dose  chemotherapy  and  autologous  bone  marrow 
transplantation. Psychooncology 2000; 9: 127-136. 
Winer EP, Lindley C, Hardee WS, Brunatti C, Borstelmann NA, Peters W. Quality of 
life in patients surviving at least 12 months following high dose chemotherapy with 
autologous bone marrow support. Psychooncology 1999; 8: 167-176. 
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Wingard JR. Quality of life following bone marrow transplantation. Curr Opin Oncol 
1998; 10: 108-111.   
Case studies  
DuHamel KN, Ostroff JS, BovbJerg DH, Pfeffer M, Morasco BJ, Papadopoulos E, Redd 
WHTrauma-focused  intervention  after  bone  marrow  transplantation:  A  case  study. 
Behav Ther 2000; 31: 175-186. 
Greece M. Art therapy on a bone marrow transplant unit: the case study of a Vietnam 
veteran fighting myelofirbrosis.  Arts Psychother 2003; 30: 229-238. 
Exercise intervention 
Baumann FT, Kraut L, Schüle K, Bloch W, Fauser AA. A controlled randomized study 
examining the effects of exercise therapy on patients undergoing haematopoietic stem 
cell transplantation.  Bone Marrow Transplantation 2010; 45: 355-362. 
Carlson LE, Smith D, Russell J, Fibich Whittaker T. Individualized exercise program for 
the  treatment  of  severe  fatigue  in  patients  after  allogeneic  hematopoietic  stem-cell 
transplant: a pilot study. Bone Marrow Transplantation 2006; 37: 945-954. 
Coleman EA, Coon S, Hall-Barrow J, Richards K, Gaylor D, Stewart B.). Feasibility of 
exercise during treatment for multiple myeloma. Cancer Nurs 2003; 26: 410- 418. 
Danaher-Hacker E, Larson JL, Peace D. Exercise in patients receiving hematopoietic 
stem cell transplantation: Lessons learned and results from a feasibility study. Oncol 
Nurs Forum 2011; 38: 216-223. 
DeFor TE, Burns LF, Gold, E-MA, Weisdorf DF. A randomized trial of the effect of a 
walking regimen on the functional status of 100 adult allogeneic donor hematopoietic 
cell transplant patients. Bio Blood Marrow Transplant 2007; 13: 948-955. 
Dimeo F, Bertz H, Finke J, Fetscher S, Mertlesmann, R, Keul J. An aerobic exercise 
program  for  patients  with  haematological  malignancies  after  bone  marrow 
transplantation. Bone Marrow Transplantation 1996; 18: 1157 - 1160.  110 
 
Dimeo FC, Stieglitz R-D, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical 
activity on the fatigue and psychological status of cancer patients during chemotherapy. 
Cancer 1999; 85: 2273-2277.  
Hayes  S,  Davies  PSW,  Parker  T,  Basford  J,    Newman  B.  Quality  of  life  changes 
following peripheral blood stem cell transplantation and participation in a mixed-type, 
moderate-intensity,  exercise  program.  Bone  Marrow  Transplantation  2004;  33:  553-
558. 
Wilson RW, Jacobsen PB, Fields KK. Pilot study of a home-based aerobic exercise 
program  for  sedentary  cancer  survivors  treated  with  hematopoietic  stem  cell 
transplantation. Bone Marrow Transplantation 2005; 35: 721-727. 
Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich 
CM, Bohus M. Effects of a partly self-administered exercise program before, during and 
after allogeneic stem cell transportation. Blood 2011; 117: 2604-2613. 111 
 
Appendix 2.1: Guidelines for submission to Psycho-Oncology  
 
 
 
Full details at http://www.wiley.com/bw/submit.asp?ref=1057-9249 112 
 
Appendix 2.2  Beatson Approval 
 
 
Our Ref:    F:/Lynda/IHTAB/290910/rg/letter 
 
Direct Line:  ++44 (0)141 301 7185                      
Direct Fax:  ++44 (0)141 301 7187 
 
29 September 2010 
 
Ms Rona Gilfillan 
Trainee Clinical Psychologist 
Dear Rona 
Re:  The impact of hematopoietic stem cell transplantation on quality of life 
among adults aged over 50 years: A qualitative investigation using semi-
structured interview methods. 
 
The  outline  proposal  submitted  to  the  In-House  Trials  Advisory  Board  on 
20August 2010 was granted approval. 
Following  this, approval granted also at the  Clinical Trials Executive Committee 
Meeting on 10 September 2010.  
Please do not hesitate to contact me should you require any further information or 
help. 
Yours sincerely 
Lynda Harper  
In-House Trials Administrator 113 
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Appendix 2.4 Greater Glasgow and Clyde Research and Development 
Management Approval 
 
Dear Ms Gilfillan, 
  
R&D Ref: GN10ON408   Ethics Ref: 10/S1001/58 
Investigator: Ms Rona Gilfillan 
Project Title: The Impact of Haematopoietic Stem Cell Transplantation on Quality of 
Life Among Adults Aged Over 50 years: A Qualitative Investigation 
Protocol Number: Version 3 dated 23/02/11 
Amendment: Substantial Amendment 1(23/02/11) 
Sponsor: NHS Greater Glasgow & Clyde 
  
I am pleased to inform you that as Sponsor we have reviewed the above 
study's Amendment 1 (23/02/11) and can confirm that Management Approval is still 
valid for this study. 
  
I wish you every success with this research project. 
  
Yours sincerely, 
  
Dr Nathaniel Brittain 
Academic Research Co-ordinator 
  
  
Dr Nathaniel Brittain 
Academic Research Coordinator 
Research and Development Directorate 
NHS Greater Glasgow and Clyde 
Research and Development Central Office 
Tennent Institute, 1st Floor 
Western Infirmary 
38 Church Street 
Glasgow, G11 6NT 
Scotland, UK  
Email:  Nathaniel.Brittain@ggc.scot.nhs.uk 
Tel: +44 (0)141 211  8544 
  
***********************************************************************
**** 
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Appendix 2.5 Covering letter and patient information sheet. 
 
 
23.02.11 Version 3 
 
 
 
 
Letter of Invitation to Participants 
Dear Participant 
Quality of Life Following Bone Marrow Transplant 
Thank you for your interest in the above named study.  My name is Rona Gilfillan and I am a 
Trainee Clinical Psychologist, studying at the University of Glasgow.  As part of my training, I 
am  currently  carrying  out  a  research  study  looking  at  the  impact  of  transplant  on  people‟s 
quality of life.   
As you will remember, your Senior Nurse asked you if you would mind being contacted about 
this study.  I now enclose an information sheet and a consent form for you to read over.   
If you decide you would like to take part in the study, I will meet with you at the Beatson West 
of Scotland Cancer Centre.  If you decide that you would prefer to have a telephone interview, 
then we can arrange a suitable time for me to call you.    Either option would involve a 90 
minute interview to find out about your experience of quality of life since your transplant.  In 
order to make sure that I fully understand your views about how transplant has impacted your 
quality of life, the interview will be tape-recorded.  All information will be treated with the 
utmost confidentiality.  However, you will understand that if something is revealed during the 
interview that suggests you or anyone else is at risk of harm, then it is my duty of care to share 
this information with other appropriate professionals.   
If you would like more information, please do not hesitate to contact me by telephone on 01236 
703 402.           
Yours Sincerely 
Rona Gilfillan  
Trainee Clinical Psychologist 
                    23.02.11 Version 3 
23.02.11 Version 3 
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23.02.11 Version 3 
 
 
 
 
 
 
Quality of Life Following Bone Marrow Transplant 
Participant Information Sheet 
Thank you for reading this information sheet.  I would like to invite you to take part in a 
research study.  My name is Rona Gilfillan and I am a trainee Clinical Psychologist at the 
University of Glasgow.  I am interested in learning about people‟s experiences of bone marrow 
transplantation and the impact this treatment has on quality of life.  You have been given this 
sheet as you may be able to help me in this study.  Before you decide if you would like to take 
part it is important for you to understand  why the research is being done and what it will 
involve.  Please take the time to read the following information carefully and feel free to discuss 
it with others if you wish.   
Please ask me any questions you have.  You can phone me on the following number (07779 729 
885) or you can leave a message and I will get back to you as soon as possible.    
What the study is about 
I  am  interested  in  understanding  your  experiences  of  quality  of  life,  such  as  physical  and 
emotional well-being, since having your transplant.  In particular, I would like to find out about 
the things that you think have changed in your life as a result of your treatment.  This type of 
research might help to inform other people who are considering having a transplant about the 
kinds of things to expect after their treatment.   
Why you are being asked to participate 
We are asking adults aged 50 years or more who have undergone a bone marrow transplant to 
take part in this study.   
Do I have to take part? 118 
 
You do not have to take part in this study.  It is up to you whether or not you wish to participate 
in the study.  If you decide to take part you will be given this information sheet and be asked to 
sign a consent form.  The consent form is a way of making sure that you know what you have 
agreed to.  If you decide to take part you are still free to withdraw from the study at any point in 
time.  If you decide to withdraw from the study at any time, this will not affect your ongoing 
medical care.     
Taking part in the study – what will I have to do? 
If you decide to take part I will arrange to meet with you at the Beatson West of Scotland 
Cancer Centre for approximately one hour.  During this meeting I will ask you questions about 
your experience of quality of life since your transplant.  I will ask you if the interview can be 
recorded (to make sure that I carefully understand your experiences and our conversation, and 
help me remember all the things we talked about).  There are no right or wrong answers, the 
research  just  wants  to  find  out  about  what  you  think  and  to  learn  more  about  your  own 
experiences.  If you would prefer to discuss your experiences in a telephone interview then I will 
arrange  a  suitable  time  to  call  you.    The  telephone  conversation  will  be  recorded  using  a 
telephone recording device.     
If you are interested in taking part you can contact me to discuss more about what would be 
involved and I will answer any questions that you have.   
Is there a down side to taking part? 
It is possible that our meeting may cover topics that are difficult or distressing to talk about.  
However, if you do not want to continue you can end the interview, or have a break, at any time.  
If  you  feel  distressed  at  all  following  the  interview,  I  will  be  available  to  talk  with  you.  
Alternatively, the department‟s Consultant Clinical Psychologist, Dr Christopher Hewitt, will 
also be available to talk with you.  For participants who decide to have a telephone interview, I 
will  pass  on  the  contact  details  of  Dr  Christopher  Hewitt  should  you  wish  to  seek  further 
psychological support.      
What are the possible advantages of taking part? 
There are no direct benefits to you in taking part in this study.  However, the information that we 
learn from  the  study  will help  us  understand  more about  quality  of  life  after  bone  marrow 
transplant.  It will also help inform others who are deciding whether or not to have a transplant, 119 
 
and help medical staff better understand the experience of treatment so that they can provide the 
best support for people. 
Will my taking part in this study be kept confidential? 
The medical doctor responsible for your treatment, usually your Consultant at the Beatson will 
know  that  you  are  taking  part  in  the  study.    However,  everything  that  you  say  during  our 
interviews  will  be  kept  strictly  confidential  and  no-one  but  myself  will  have  access  to  the 
recordings of the interviews.  Your name, or other identifying information will not appear in any 
reports.  With your permission, anonymous quotes of what you have said may be used in the 
report.   
Are there any circumstances when information shared by me during the interview would 
not be kept confidential? 
Everything you say during the interview will be kept private.  However, if you tell me anything 
that  suggests  that  you  or  anyone  else  is  at  risk  of  harm,  then  it  is  my  duty  to  share  this 
information with other appropriate professionals.   
What will happen to the results of the research study? 
I will provide you with a summary of the results of the study.  The final results and conclusions 
of the study may be published in a scientific journal and will form part of my qualification in 
Clinical Psychology.  Your identification will not be included in any publication.   
Who is organising and funding the research? 
The University of Glasgow 
Who has reviewed the study? 
The  study  has  been  reviewed  by  the  Department  of  Psychological  Medicine  at  Glasgow 
University  to  ensure  that  it  meets  important  standards  of  scientific  conduct  and  has  been 
reviewed by the West of Scotland Research Ethics Committee to ensure that it meets important 
standards of ethical conduct.  The study has also received organisational approval from the 
Beatson West of Scotland Cancer Centre and has been given management approval by Greater 
Glasgow and Clyde Research and Development.      120 
 
Thank you very much for reading this and for any further involvement you may have with the 
study.      
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Appendix 2.6 Patient consent form 
23.02.11 Version 3Cross reference to PIS 23.02.11 Version 3 
 
 
 
Quality of Life Following Bone Marrow Transplant 
Participant Consent Form 
Please  put  your  initials  in  each  of  the  boxes  to  show  that  you  have  read  and  are  in 
agreement with the statements: 
 
I confirm that I have read and understand the information sheet for the above study 
and have had the opportunity to ask questions        
                                      
I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving a reason, without my medical care or legal rights being affected 
   
I understand that the medical clinician who is involved in my care (Doctor or Nurse at the 
hospital) will be informed of my participation in the research 
   
I agree to my GP being informed of my participation in the above study                                              
   
I understand that as this is a telephone interview, a telephone recording device will be used to 
tape the interview solely for the purpose of the research study as described in the Participant 
Information Sheet and will be kept confidential                                           
I understand that quotations may be published but that all names, places and identifiers will be 
removed beforehand 
   
I agree to take part in the above study 
   
Name of Participant                                     Date                                              Signature 
 
Researcher                                                   Date                                              Signature 
 
Thank you for taking part in this study 
(1 copy for participant and researcher and 1 copy for medical notes)    
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Appendix 2.7:  Semi-Structured Interview Schedule     
 
 04.10.10 Version 1 
 
Quality of Life Following Bone Marrow Transplant 
 
Interview Guide 
 
 
The interview guide is based on relevant issues from the research literature. 
1.  Can you tell me what led up to you first seeking medical attention? 
 
2.  What does the term “quality of life” mean to you? 
 
3.  Can you tell me about what life has been like since your transplant? 
 
4.  What impact on your life (if any) do you think treatment has had? 
 
5.  How has life changed (if at all) since having your treatment? 
  Can you tell me about any negative changes? 
  Can you tell me about any positive changes? 
  Why do you think this is? 
 
6.  How do you view your quality of life now as compared with before you received the 
transplant? 
 
7.  What has been the biggest change in your life since having treatment?  What do you 
think has caused this change? 
 
8.  What are your main concerns/worries? 
 
9.  Can you tell me about your expectations for the future? 
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10. Is there anything you wish you had known about before having the transplant? 
 
11. If you could turn the clock back, would you undergo the transplant again? 
 
12. Before we finish, is there anything about your experiences we have not covered that you 
would like to share? 
 
Example Probes 
 
  Can you tell me more about that? 
  What does that mean for you? 
  Could you give me an example of that? 
  How does that make you feel? 
  What do you think about that? 
  What is that like for you? 
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Abstract  
  Background: Quality of life (QOL) research in the field of haematopoietic stem 
cell transplantation (HSCT) has added greatly to our understanding of the impact 
of this demanding medical procedure.  However, little is known about the QOL 
experienced  by  recipients  aged  50  years  or  more  who  undergo  a  reduced 
intensity conditioning treatment (RIC) prior to unrelated allogeneic HSCT.   
  Aims:   This study aims to add to the 3 existing quantitative studies that have 
looked at QOL among these RIC HSCT recipients and gain greater insight into 
the  impact  of  treatment  on  QOL,  which  may  be  missed  by  standardised 
questionnaires.   
  Methods:  This  study  aims  to  use  qualitative  methods  to  investigate  adults‟ 
perceptions of the impact that RIC HSCT has on their QOL, by developing a 
comprehensive list of themes through thematic analysis.  
  Applications: HSCT is a life changing event and it is therefore essential that 
individuals are prepared as much as possible for the ways in which their QOL 
may alter.  By identifying similarities and differences in the QOL experienced by 
this particular group of HSCT recipients, clinicians can be better informed as to 
how best support those individuals most likely to experience significant QOL 
issues post-HSCT.  
 
Introduction: 
There continues to be a lack of agreement regarding the conceptual definition of quality 
of life (QOL) and its subsequent operational definition (Hacker, 2003).  However, most 
would agree that QOL is a multidimensional concept involving four core domains of 
functioning; psychological, social, occupational, and physical (Fallowfield, 1990).  This 
definition reflects the influence of the biopsychosocial approach to the development of 
QOL as a construct (Moffat et al. 2009).  QOL evaluation therefore requires a holistic 
view of the impact of illness and medical treatment.  This approach is invaluable since  
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survivors  of  diseases  such  as  cancer    report  issues  related  to  QOL  as  among  their 
greatest concerns (Baker et al., 2005).   
 
Haematopoietic stem cell transplantation (HSCT) is a treatment most often performed 
for  individuals  with  certain  types  of  haematological  cancer.    The  number  of  HSCT 
survivors  is  rapidly  increasing,  as  more  than  45,000  people  undergo  the  procedure 
annually  throughout  the  world  (Mosher  et  al.,  2009).    Although  HSCT  offers  the 
potential of cure in 50% of patients who undergo the procedure, it is one of the most 
taxing cancer treatments to endure (Rusiewicz et al., 2008), generating serious QOL 
issues due to the potential for accompanying physical and emotional distress (Baker et 
al.,1999).  HSCT involves the transplantation of haematopoietic stem cells derived from 
peripheral blood, cord blood, or bone marrow and the procedure varies depending on the 
type of transplant an individual is receiving.  The different types of transplant are known 
as: autologous (i.e. the cells are taken from the patient and returned once chemotherapy 
has  been  given  to  eradicate  malignant  cells);  sibling  allogeneic  (i.e.  cells  are 
transplanted from a matched sibling); or unrelated allogeneic (i.e. cells are transplanted 
from  a  voluntary  donor  (VUD)  or  cord  blood).    Allogeneic  transplants,  as  well  as 
autologous,  involve aggressive pre-conditioning treatments prior to transplant, known 
as  myeloablative  conditioning.    This  involves  the  patient  receiving  high-dose 
chemotherapy  and  radiotherapy  to  “eradicate  residual  disease  and  recipient  (host) 
immunity in preparation for healthy donor-derived haematopoietic stem cells (graft)” 
(Shelburne & Bevans, 2009, p. 120).  
 
Regardless  of  the  source  of  stem  cells,  HSCT  is  associated  with  a  common  set  of 
biopsychosocial issues (Andrykowski & McQuellon, 2004).  The treatment itself is life 
threatening and the uncertainty surrounding its outcome causes individuals significant 
stress (Thain & Gibbon, 1996).  Due to the aggressive nature of the treatment, there are 
a number of side-effects including fatigue, nausea, mucositis and hair loss.  Allogeneic 
HSCT is associated with graft-versus-host disease (GVHD), which involves attacks by 
donor marrow on the recipient‟s organs and can result in serious complications which  
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are significant threats to QOL (Neitzert et al., 2009a).  Often, individuals remain in 
hospital for a period of time post-transplant and their progress is monitored.  This is an 
anxiety provoking time as recipients wait to hear about the success of the treatment.  
There is evidence that the greatest psychosocial stressors facing individuals at this post-
transplant stage are pain and thoughts about their survival or possible death (Haberman, 
1988; Steeves, 1992).  In short, HSCT recipients experience an array of taxing physical 
stressors  within  the  context  of  psychological  and  social  stressors  associated  with 
medical uncertainty and life threat (Andrykowski & McQuellon, 2004).  
 
From the patient‟s perspective, a successful HSCT does not mean only that the patient 
survives.  Patients also want a good QOL after transplant (Stewart, 2004).  Ferrell et al., 
(1992a) were among the first to conceptualise QOL in HSCT patients.  In a large sample 
(n = 119) of bone marrow transplant  (BMT) survivors,  these investigators  collected 
qualitative data regarding the meaning of QOL to BMT survivors and the impact of the 
transplant on QOL.  They developed a conceptual model depicting the impact of BMT 
on QOL involving four main areas: physical wellbeing and symptoms, psychological 
wellbeing, social wellbeing, and spiritual  wellbeing.  In the same study, the themes 
developed  in  relation  to  the  meaning  of  QOL  referred  to  being  healthy,  having  a 
heightened appreciation for life, having family and relationships, being normal, being 
satisfied and fulfilled with life, being able to work and experience financial success, 
being independent,  being alive, and having self-esteem  and self-respect.   In another 
study, Ferrell et al., (1992b) tried to discover individual perceptions of what makes QOL 
better or worse.  The themes developed in this study were similar to those described in 
the  previous  work.    However,  experiencing  physical  losses,  breaking  relationships, 
having unfulfilled goals, and being financially distressed made QOL worse.  
 
A large number of cross-sectional surveys have investigated QOL for HSCT patients 
from pre-transplant through approximately 10 years post-transplant.  As a result, much 
is known about QOL outcomes of transplant over time for HSCT recipients within and  
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across diagnoses (Syrjala, 2004).  The central consistent findings of these studies are 
that: 
1.  physical  function  returns  to  pre-transplant  level  for  approximately  75%  of 
survivors by 1 year; 
2.  by 3 years, 80-90% of survivors are back to full time work; 
3.  the  majority  of  patients  manage  the  challenges  of  HSCT  with  good 
psychological health; and 
4.  a minority of patients will have major residual problems with a variety of QOL 
functions                                                                                                  (Syrjala, 
2004).  
 
Despite positive reports of outcome studies, in terms of long-term recovery from HSCT, 
there  is  wide  variability  in  the  trajectory  of  recovery  (McQuellon  et  al.,1998).  
Unfortunately some recipients never fully recover, both physically and psychosocially, 
from  their  HSCT  experience,  while  for  others,  recovery  requires  a  lengthy  journey 
(Andrykowski & McQuellon, 2004).  Returning to “normal” depends on each recipient‟s 
perspective, however, even with the return of what they consider a normal lifestyle, few 
recipients are left unchanged by their HSCT experience (Stephens, 2005).  Andrykowski 
and McQuellon (2004) summarise some of the late effects of HSCT.  These include 
pulmonary  problems,  cataracts,  sterility,  endocrine  dysfunction,  chronic  GVHD  and 
weakness  and  fatigue.    Even  without  late  effects,  most  recipients  experience  some 
interruption  in  normal  developmental  tasks,  for  example,  maintaining  a  career  and 
establishing satisfactory marital and family relationships in the case of adult recipients.  
Psychosocial  sequelae  of  HSCT  such  as  anxiety,  depression,  strained  interpersonal 
relationships, or even PTSD may persist for months or years after HSCT (Mosher et al., 
2009; Andrykowski & McQuellon, 2004). 
 
However, positive psychosocial changes can also stem from the HSCT experience, such 
as families being brought closer together (Holmes et al., 1997).  A recent review of QOL 
post  HSCT  highlighted  a  number  of  studies  that  have  identified  benefits  of  the  
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experience (Pidala et al., 2009b).  Such studies report positive outcomes including an 
enhanced appreciation for life, greater feelings of love and appreciation for family and 
friends,  improved  self-esteem,  new  priorities  in  life  and  the  perception  of  a  new 
meaning in life (Pidala et al., 2009b; Andrykowski & McQuellon, 2004).  This “post-
traumatic growth” is theorised to result from adaptation to the trauma of HSCT (Pidala 
et al., 2009b).  Therefore, recovery after HSCT involves the experience of both positive 
and negative outcomes.  
 
Given  the  risks  associated  with  HSCT,  particularly  a  myeloablative  conditioning 
regimen, the treatment has been preferentially used for younger patients as older age has 
been one of the most significant factors that adversely affect outcome.  However, a more 
recent treatment approach using reduced intensity conditioning (RIC) regimens prior to 
HSCT    is  associated  with  a  lower  risk  of  transplant  related  mortality  and  therefore 
allows  patients  who  are  considered  too  high-risk  for  conventional  myeloablative 
allogeneic HSCT, due to increased age or co-morbidities, to undergo potentially curative 
therapy for their disease.  These new transplant strategies are now being used more 
widely with older patients who would have previously been considered unfit for HSCT 
(Shelburne & Bevans, 2009).  
 
Although research has shown encouraging results for older patients undergoing RIC 
treatment in terms of survival (Shelburne & Bevans, 2009; Pidala et al., 2009a; Storb, 
2007), little is known about the nature of that survival.  Despite the large amount of 
research pertaining to QOL after HSCT, informing our understanding of recovery for 
the majority of recipients, inadequate data prevent any conclusions on QOL for patients 
over age 50 (Syrjala, 2004). Furthermore, since HSCT is recognised as a life changing 
event, causing interruption in normal developmental tasks (Andrykowski & McQuellon, 
2004), our understanding of the meaning and impact of this for recipients aged over 50 
years is far from clear.  Just as little is known about older recipients‟ experience of 
HSCT, it is equally true that research is limited in terms of our understanding of the 
impact  of  RIC  treatment  itself  on  recipients‟  QOL  (Shelburne  &  Bevans,  2009).   
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However,  it  may  be  the  case  that  different  treatment  regimens  are  associated  with 
distinctive physical and/or emotional side-effects impacting individuals‟ QOL (Neitzert 
et al., 1999).  Therefore, the impact of RIC HSCT on the QOL of recipients aged 50 
years and over remains inconclusive.  
 
To date there have been only 3 quantitative studies looking specifically at recipient QOL 
following RIC HSCT (Diez-Campelo et al.,  2004; Bevans et al., 2006; Andersson et al., 
2009).  These 3 prospective studies produced some mixed findings.  For example, Diez 
Campelo et al., (2004) compared the QOL of 47 RIC recipients to 70 autologous HSCT 
recipients.  Health related QOL was measured at seven points during the first year post 
transplant, with a questionnaire based on the Functional Assessment of Cancer Therapy 
(FACT) – BMT and items relating to GVHD.  In terms of outcomes, this study found 
that the RIC recipients reported significantly better physical functioning compared with 
autologous  recipients  during  the  first  year.    No  significant  differences  were  found 
between either group of recipients for any of the functional, social/family, psychological 
distress items.  Bevans et al., (2006) compared the QOL of 41 RIC recipients to 35 
conventional allogeneic recipients.  Health related QOL was measured using the Short 
Form – 36 Health Survey and the FACT – general and BMT at 6 points during the first 
2 years post transplant.  The results showed that both groups of patients experienced a 
similar improvement during early recovery and no significant differences were found 
between the groups across the various domains of QOL.  These findings may indicate 
that  RIC  HSCT  impacts  QOL  in  a  manner  more  similar  to  conventional  allogeneic 
HSCT than autologous HSCT.  However, the results of Andersson et al.‟s (2009) study 
add further evidence making conclusions about this less clear.  The authors compared 
the QOL of 32 RIC recipients to 25 conventional allogeneic recipients.  Health related 
QOL was measured at 6 points during the first year post transplant using the European 
Organisation  for  Research  and  Treatment  of  Cancer  Quality  of  Life  Questionnaire 
(EORTC  –  QLC  –  C30  and  the  19  item  treatment-specific  module  High  Dose 
Chemotherapy (HDC – 19).  This study found that both groups reported most symptoms 
and worst functioning one month post transplant, but there were substantial differences, 
with the conventional allogeneic group doing worse than the RIC group.  Overall, RIC  
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recipients were found to regain health and QOL faster than the conventional group.  
However,  no  significant  differences  in  global  QOL  were  found  at  one  year  post 
transplant.  Therefore, there is some contradictory evidence in terms of early recovery 
post transplant and it remains unclear whether QOL is significantly better during early 
recovery  post  RIC  than  conventional  allogeneic  transplant.    In  addition,  the  use  of 
different measures in these studies may contribute to the mixed findings.  Thus, it is not 
yet possible to be conclusive as to the impact of RIC HSCT on recipients‟ QOL.   
 
The issue of measurement of QOL is highlighted by Hacker in her review of quantitative 
research, as she notes, “Studies operationalising QOL from different conceptualisations 
frequently result in different findings even for the same group of people” (Hacker, 2003, 
p. 614).    Furthermore, no qualitative research has been conducted with this group, 
despite this methodology being particularly appropriate in addressing one of the major 
questions for outcomes research in this area, “What is the patient‟s experience with 
HSCT?” (Lee, 2004).  Qualitative methods have been used in several studies to evaluate 
aspects of recovery following HSCT and these studies revealed several themes that are 
not particularly well covered in standardised instruments; for example, strategies that 
patients use to compensate for limitations, the multiple losses across various aspects of 
their lives and the greater appreciation for life brought about by the HSCT experience 
(Lee, 2004).  Therefore, the use of standardised questionnaires may lead to a potentially 
incomplete  picture  of  QOL  (Fromm,  Andrykowski  &  Hunt,  1996).    Furthermore, 
patients themselves report their dislike of aspects of standardised questionnaires and 
report  reasons  such  as,  the  questionnaire  “did  not  address  spiritual  life,  changes  in 
perspective etc.”, “put words in mouth” should be more in depth” and “asked specific 
questions with no place for explanation” (Byar, Eilers & Nuss, 2005, p. 152-153). 
 
Given the lack of knowledge about the holistic experience of RIC HSCT recipients aged 
over 50 years, this study aims to add to the existing quantitative studies that have looked 
at QOL among these recipients and gain greater insight into the impact of treatment on 
QOL, which may be missed by standardised questionnaires.    
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Research Question 
An exploration of the QOL experienced by adults aged 50 years or more following RIC 
HSCT. 
 
Aims 
The  study  aims  to  use  qualitative  methods  to  investigate  adults‟  perceptions  of  the 
impact that RIC HSCT has on their QOL, by developing a comprehensive list of themes 
through qualitative analysis. The specific aims of the study are: 
  To  identify  the  impact  RIC  HSCT  has  on  QOL  from  an  adult  recipient‟s 
perspective 
  To identify age-specific concerns in relation to QOL 
 
Plan of Investigation 
Participants 
Those individuals who have undergone RIC HSCT at different time points over the last 
5 years, and are aged 50 years or more at the time of transplant.  A review of the 
database held at the Beatson West of Scotland Cancer Centre (BWoSCC) indicated that 
approximately  20  patients  would  qualify  as  potential  participants  for  this  research.  
Potential participants will be outpatients who are attending the BWoSCC for review 
appointments.  
Inclusion Criteria 
RIC  HSCT  recipients  aged  50  years  or  more  at  time  of  transplant  who  attend  the 
BWoSCC for review appointments.  Participants must be English speaking.      
 
Exclusion Criteria 
Substance misuse or dependency, or a learning disability.  Those recipients identified by 
Medical staff as unsuitable for the study.    
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Recruitment Procedures 
Prior to recruitment, a list of participants identified as meeting inclusion and exclusion criteria 
will be given to Medical Consultants who will be able to advise as to any reasons why they 
should not be contacted.  Patients would be recruited through out-patient clinic and annual 
review meetings.  For recipients attending the BWoSCC regularly, the primary medical staff 
involved in participants‟ care will advise recipients of the research and pass on information 
leaflets.  Recipients will then be able to complete a consent form indicating their permission for 
the researcher to contact them about the study.  For recipients who attend less frequently, at late 
effects  clinics,  information  leaflets  will  be  sent  out  with  their  appointment  reminder  letter.  
Again,  interested  recipients  can  return  the  consent  form  indicating  their  permission  for  the 
researcher to contact them about the study, in order to arrange a suitable time to meet.  For those 
recipients who are unable to meet due to travel restrictions but wish to participate, a telephone 
interview will be arranged for a suitable time.       
 
Design and Procedure 
In-depth,  semi-structured  interviews  will  be  conducted  on  an  individual  basis.    The 
interviews will be audio-taped and transcribed verbatim.  It is anticipated that a list of 
interview questions will be used to help guide the interview.  These will be developed in 
line with the research literature pertaining to QOL and HSCT and consistent with the 
aims of the study.  To enhance the validity of the data, the questions will be checked by 
staff  experienced  in  the  care  of  HSCT  recipients  in  order  to  ensure  the  questions 
adequately represent the research topic.  The questions will be open-ended to allow for 
participants‟ individual interpretation and exploration of the issues.  Probe questions will 
be  used  to  obtain  further  information  about  particular  issues.    The  semi-structured 
format is considered appropriate to explore individuals‟ perceptions of quality of life 
and the factors influencing it (Holmes et al., 1997).  
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Analytical procedure will be iterative, whereby the researcher will collect data through 
interviews, reflect upon the data and note emerging themes.  A reflective diary will be 
kept throughout in order to facilitate the development of the researcher‟s subjective, 
reflexive views (Grbich, 1999).  
   
Justification of sample size 
Power  calculations  are  not  appropriate  in  qualitative  research  as  sample  size  is  not 
predetermined.  The goal of qualitative studies is to capture the breadth of possible 
patient  attitudes  or  experiences.    In  contrast  to  quantitative  studies  in  which 
generalisability is critical, the goal of qualitative studies is not to obtain a statistically 
representative sample, but rather to achieve “symbolic representation”.  That is, “a unit 
is chosen to both represent and symbolise features of relevance to the investigation” 
(Ritchie  &  Lewis,  2003,  p.  83).    In  fact,  purposive  or  targeted  sampling  can  be 
performed in order to ensure the spectrum of possible patient experiences is represented 
(Lee, 2004).  Non-probability sampling will be used in order to select information-rich 
cases (Grbich, 1999).  Data gathering will cease when it is evident that new data “no 
longer spark new insights” (Charmaz, 2003).  This sampling technique means that the 
number  of  cases  is  unpredictable,  however,  it  is  anticipated  that  a  sample  size  of 
approximately  8  will  allow  for  sufficient  detailed  analysis  of  the  data  (Turpin  et 
al.,1997) and is feasible within the context of a D.Clin.Psy research project.   
 
Settings and Equipment 
The Beatson West of Scotland Cancer Centre. Digital recording equipment. Qualitative 
analysis  software.  Telephone  recording  device  for  telephone  interviews.    For  these 
interviews, the researcher would use a telephone in a private office at the Academic Unit 
of Mental Health and Wellbeing at the Academic Centre at Gartnavel Royal Hospital.   
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Data Analysis 
A thematic approach will be taken to data analysis (Braun & Clarke, 2006).  Data will 
be transcribed verbatim into written form, allowing the researcher to begin the process 
of becoming familiar with the data.  The researcher will then repeatedly read the data in 
an active way, searching for meanings and patterns in order to become “immersed” in 
the  data.    Note  taking  will  begin  at  this  stage  and  initial  ideas  for  coding  will  be 
documented.  Initial codes will be produced from the data and, to some extent, will 
depend on whether the themes are “data-driven” or “theory-driven” (Braun & Clarke, 
2006).  Coding can be conducted either manually or through a software package.  It is 
important to code for as many potential themes and patterns as possible at this stage and 
to  include  contradictory  themes  as  these  may  add  to  our  understanding  of  the 
experience.  This initial coding frame will be shared with the academic supervisor to 
increase the reliability of the coding process.  In order to minimise subjectivity and bias, 
the academic supervisor will blind code a proportion of the data to increase reliability.  
Themes  will  then  be  searched  for,  reviewed  and  defined.    Thematic  interpretative 
analysis of the data requires that any claims made as a result of analysis be “grounded 
in, but go beyond the surface of the data” (Braun & Clarke, 2006, p. 94).    
 
Health and Safety Issues 
Researcher Safety Issues 
All interviews will take place at the Beatson West of Scotland Cancer Centre.  The field 
supervisor  and  participants‟  medical  consultants  will  be  aware  of  the  scheduled 
interviews  and  de-briefing  sessions  will  be  arranged  between  researcher  and  field 
supervisor.  For  participants  who  decide  to  take  part  in  a  telephone  interview,  the 
researcher will use a telephone in a private office at the Academic Unit of Mental Health 
and Wellbeing  at  the Academic Centre at  Gartnavel  Royal  Hospital.    All  telephone 
interviews would take place within normal weekday working hours between 9am to 
5pm.    
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Participant Safety Issues 
By nature of the research, participants will all have undergone an aggressive medical 
treatment  for  their  cancer  and  therefore  their  physical  health  status  may  well  be 
compromised.    The  researcher  will  endeavour  to  provide  a  comfortable  setting  for 
participants  during  research  interviews.    It  is  estimated  that  interviews  will  last 
approximately 60-90 minutes.  Refreshments will be provided.    It is recognised that 
this  study  will  involve  participants  discussing  potentially  distressing  subjects  and 
emotional support may be required.  The researcher is trained to manage individuals‟ 
distress in a supportive manner and should participants wish to receive psychological 
support, they will be able to meet with the consultant clinical psychologist based within 
the  BWoSCC.    This  provision  will  be  made  explicit  to  participants  prior  to  their 
interview.  For participants who decide to take part in a telephone interview, they will 
also be advised of the clinical psychologist‟s contact details should they wish further 
psychological support.   
 
 
 
Ethical Issues (including where submissions will be made) 
The transplant team at the BWoSCC reported their belief and experience that many 
patients are keen to discuss their experiences.  Applications to the Local Research Ethics 
Committee and the Beatson Trials Executive Committee would be submitted.  Potential 
participants  will  be  informed  of  the  study  by  their  Medical  Consultant.    A  patient 
information leaflet will be passed on to participants via the consultant, emphasising that 
participation is entirely voluntary.  Refusal to take part in the study will in no way 
impact ongoing medical care.  Participants will be able to complete and sign a tear-off 
slip  and  return  to  the  researcher  indicating  their  consent  to  be  contacted  by  the 
researcher.  Participants who do not wish to take part in the study do not need to return  
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the consent form.  Participants will be free to withdraw from the study at any point and 
this will in no way impact their medical care.   
 
Financial Issues 
Equipment costs, travel etc. 
20 sheets of headed paper (photocopied)  (5p per sheet) 
20 A4 envelopes 
Freepost for 20 participants (35p per letter) 
Digital recorder and transcription software:  Qualitative software QSR Nvivo Student 12 
month.    This  should  be  provided  via  the  Section's  current facilities  for  qualitative 
research. 
Sony ECM TL1 telephone recording device - £23.99.  This will be ordered and paid for 
by the Section.   
Timetable 
April 2010 – Submit major research project proposal to course 
August 2010 – Submit application to ethics committee 
October 2010 – Begin data collection. Transcription and analysis of data will  begin 
following the first interview to help inform future interviews 
October 2010 to March 2011 – Ongoing data collection and analysis 
April 2011 to June 2011 – Write up   
July 2011 – Submit major research paper to course 
 
Practical Applications 
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QOL data provide clinicians and patients with supplementary information to guide their 
treatment decisions and this helps keep the patient at the centre of care provision.  This 
information is invaluable to patients who are faced with decisions which are clouded 
with uncertainty.  In addition to aiding the decision making process, it is hoped that the 
findings from this study will help identify specific issues relevant to QOL among this 
group, which will in turn help clinicians in their ongoing evaluation of HSCT recipients‟ 
QOL.  This knowledge could help ensure that particular issues are addressed during 
follow-up consultations which would allow recipients to then receive the appropriate 
support and intervention.  The in-depth nature of the research would allow exploration 
of the subjective experience of a sub group of HSCT recipients which may well be 
different to other HSCT survivors, due to their increased age and particular treatment 
regimen.    By  establishing  similarities  and  differences  between  sub-groups  of  HSCT 
recipients, it is possible to identify and target HSCT survivors at greatest risk for long 
term psychosocial difficulties, thus enabling clinical management efforts to be focused 
upon these individuals (Andrykowski & McQuellon, 2004).  HSCT is a life changing 
event and it is therefore essential that individuals are prepared as much as possible for 
the ways in which their QOL may alter.  It is currently not possible to fully inform RIC 
HSCT recipients of these changes, due to the lack of research. However, the proposed 
study would aim to add to current knowledge base and help inform recipients about 
QOL  after  RIC  HSCT.    It  is  hoped  that  research  findings  would  contribute  to  the 
development of a handbook for individuals considering RIC HSCT.  
 
Dissemination 
The  results  of  the  study  will  be  written  up  and  submitted  to  the  West  of  Scotland 
Doctorate in Clinical Psychology Programme for examination purposes.  It is hoped that 
the final results and conclusions of the study will be published in a scientific journal.   
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Text  Initial Theme  Master Theme  Super ordinate Theme 
James:  for somebody that did you know a pretty 
responsible job and uh had a very busy life, it was a 
complete turnaround. (L191) 
loss of old self 
 
Changed sense of self 
 
Shifting sense of self 
and others 
 
David:  I didn‟t find it easy cause I‟ve been pretty 
independent all my life (L582)... Well, it makes you 
feel yourself to be less than you were.  (L628) 
loss of independent 
self and self-esteem 
Harold:  But, what I find particularly frustrating is the 
loss of my vision...Because that‟s been the basis of my 
whole life really.  (L206)   
loss of identity 
Geoff:  I went in to the transplant with a physical age 
maybe ten years younger than, eh, than my, sort of, 
normal age group.  So, I, I think probably, probably 
one of the biggest shocks has been to age ten years in 
one.  (L184)   
transformed 
physical identity 
 
James: Well, you end up...just having almost well a 
completely different way of life really.  (L157)   
separation, 
fragmentation, 
disconnection felt 
within family unit 
Changed family life 
 
David:  It‟s distanced us a bit (L508)    changed family 
relationships 
Mary:  brought us closer (L355)    changed family 
relationships 
Paul:  I see them more now (L736)  changed family 
contact 
Paul:  they‟ll no let me go on holiday...and [wife‟s 
name] loves the sun (L297)   
normal family 
activities disrupted 
Geoff:  I slip off for an afternoon‟s snooze but that 
does limit the sort of things that we can do together as 
a couple. (L327)   
interfering with 
joint family 
activities  
Mary:  I mean that‟s – it‟s not really a problem until I 
think, “Well, I should be going through and seeing my 
mum this weekend” (L541)   
impact on family 
roles and 
responsibilities 
 
 
 
1
4
3
 
Appendix 2.9 Summary Table of Master and Super ordinate themes developed from Initial themes  
 
Helen:  Em, although there‟s no guarantees but within 
myself I felt [pause] more, em, how will we say, at 
peace with myself. (L218)  
improved emotional 
state 
Changed emotional wellbeing 
 
Shifting sense of self 
and others 
 
Mary:  more positive about the future (L317)    more optimistic 
Geoff:  y‟know, you‟re always looking over your 
shoulder and – is it coming back again?  I think this is, 
this is a much better situation that I‟m in.  (L557)  
alleviation of 
worries 
Isobel:  The way I see it now y‟know, I‟m hoping to be 
here to see my grandchildren get married and 
y‟know, graduate...when I was ill, I couldn‟t see 
that...But now... I can see that happening. (L464) 
able to see a future 
life/more hopeful 
 
Harold:  I‟m slightly more optimistic (L280)    more optimistic 
now 
Paul:  I get awfully emotional...every time I take a cold 
now, I worry (L150; L577)   
increased anxiety 
and negative 
emotions 
Harold:  Well, I just find other things to do...there‟s no 
point trying to be stuck – life is change (L365)   
using adaptive 
coping strategies 
and thinking style  
Coping 
 
Adaptation and 
managing the 
impact 
 
Geoff:  Well, you‟ve just got to get a balance really 
(L529)   
adapting and 
coping 
James:  I set small targets (L267)    using goal setting 
Isobel:  I think if you go back to what you had and 
wishing that you could have that back – I think that 
would play on your mind...I think it would give you 
mixed feelings (L587)   
 
using adaptive 
thinking styles to 
cope 
David:  I‟m not going to worry about it (L489)   adaptive coping 
style  
Paul:  I just go quiet.  I tend to keep myself to 
myself...dinnae do an awful lot (L582)   
 
maladaptive coping 
 
Mary:  I think when I feel like that I think, “well 
you‟ve got to make the most of what you‟ve 
got”.(L131)   
 
using adaptive 
coping style – 
positive thinking 
43
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4
  
 
Harold:  I know people who haven‟t had transplants 
who are just older, getting old, getting on – experience 
diminished capacity and it‟s hard for them to cope with 
things the same as it is hard for me. (L334)   
being older 
normalises the 
losses associated 
with HSCT 
Age and stage of life 
 
Adaptation and 
managing the 
impact 
 
Isobel:  .  Em, if I was a younger person, I would 
maybe hope to have more go... if I was maybe in my 
twenties and thirties y‟know, like, being more physical 
with, y‟know sports and that – I would feel y‟know, 
that would affect me.  But, now I‟m older – no (L535) 
being older makes it 
easier to cope with 
reduced physical 
capacity and 
activities 
Mary:  we‟re getting to that age when we‟re all falling 
to bits, I think [both laugh]. (L564)   
age and stage of life 
normalises 
experience of health 
problems and 
facilitates positive 
social comparisons 
to age similar peers  
James:  I was beginning to think of retiring in a year or 
so‟s time anyway, so it probably wasn‟t as big a 
decision as it really would have been a couple of years 
ago (L244)   
 
age and stage of life 
buffers potential 
biographical 
disruption 
Helen:  [Husband‟s name] retired at the end of 
August...So, I mean, it was just a blessing as well that 
you know, in a way, that he didn‟t have a full time job, 
because, that would have been a real strain on him and 
myself. (L626)   
 
being at older stage 
of life helps reduce 
burden on self and 
family 
James:  I had a very good network of friends that kept 
coming and seeing me...it lifts you up (L194)   
 
social support helps 
mood   
 
Social support 
 
 
 
 
Mary:  she was a church visitor... I think it made a 
difference because she wasn‟t involved in looking after 
me.  She didn‟t know what I had or – she was just 
someone who came in and had a chat and went off 
again. (L764)   
 
social support helps 
reduce 
 illness identity and 
role 
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Paul:  having [names of family members] there...it 
keeps me going (L740)   
social support helps 
with motivation  
 
 
 
 
 
 
 
Social support 
 
Adaptation and 
managing the 
impact 
 
Helen:  another factor that did make a big, big 
difference to me was the support I got from my 
husband.  (L615)   
social support helps 
 
Geoff:  the two of them have, have been very 
supportive of me and providing meals and one thing or 
another.  (L344)   
social support helps 
with practical needs 
Isobel:  my husband had come with me and my sister 
was there and they kind of pushed me after my 
transplant...to get out of bed...It was an effort but 
y‟know, they pushed me.  So, I think the more support 
you have the better it is for you.  Myself, anyway, if I 
didn‟t have the support I don‟t think I would have been 
able to, y‟know – cope.  (L364)   
 
social support helps 
you cope and 
motivates you 
 
Harold:   being married and having – my wife was with 
me the whole time and sitting in the room really, day 
and night and so that made a big difference (L286)  
social support helps 
Paul:  I used to get really angry at things...But now, I‟d 
try to talk something through rather than lose the head  
(L405)  
improved 
interpersonal style 
 
 
 
 
 
Personal growth and benefit 
 
 
 
 
 
 
 
 
 
 
 
 
 
A new perspective 
on life and living 
 
 
 
 
 
 
 
Mary:  I think you‟re much more accepting.  I think 
you‟re less judgemental...you just appreciate em, what 
some people – you know I hate coming in here – em, 
what some people have to put up with and go through.  
(L496)   
 
more appreciative 
and tolerant 
 
Helen:  I‟d never given any thought to the spiritual or 
religious part of life really...one thing 
I‟m sure of is...There are miracles out there, I believe 
that.  (L668)   
enhanced spiritual 
wellbeing   
 
James: it‟s pushed me into a decision to uh, maybe 
think a bit more about myself rather than my work 
which all consumed me for the last 20 years. (L392)   
 
more aware of own 
needs 
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Geoff:   I think I‟m much more sympathetic to other 
people and just the realisation that, well, for a while, I 
kind of feel like the whole world revolves around you 
and your illness – you suddenly become aware that 
everybody‟s got these problems.  (L466)   
 
more appreciative 
and understanding 
of others   
 
 
 
           Personal growth and benefit 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A new perspective 
on life and living 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mary:  I used to think that I would travel quite a lot – I 
don‟t now...I‟m quite happy to be at home.  I think it‟s 
because you spend so much time away from home.  
(L292)   
redefining future 
priorities   
 
Changed priorities 
 
James:  I put far too much over the years personally 
into work really...I‟ve decided to take early 
retirement and get some quality of life back (L239)   
change in work 
priorities and 
definition of 
QOL 
 
Geoff:   I do feel that I shouldn‟t be wasting what time 
I‟ve been given...I need to be doing something positive 
with it.  (L447)   
new priorities – to 
use time more 
meaningfully  
 
Harold:  it‟s really time to retire now and take up 
another interest in life and find other ways of em, 
living.  (L100)   
 
establishing new life 
priorities 
Geoff:  the immune system is ineffective but at least 
the haemoglobin levels have recovered, so that‟s 
brilliant (L196)   
physical losses are 
worth the gains  
 
 
 
 
Reappraising and accepting- the losses 
are worth it 
 
 
 
 
 
Mary:  So, regardless of missing – you know there 
were quite a few things this winter that I had to cancel 
– em, which was disappointing, but you know, at the 
end of the day, you know, there‟s still tomorrow. 
(L283)  
 
although social life 
disrupted, it’s 
worth it for the sake 
of having a future 
Paul:  I wouldnae say anything‟s changed for the 
better...physically – I‟m worse.  Eh, mentally, 
probably...I don‟t really do anything  (L772)   
 
unable to see any 
gains – losses 
outweigh the gains   
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David:  I don‟t know whether I will get fully back 
obviously but y‟know – as long as I can get a long way 
back, y‟know, it‟s good.  (L684) , the other option is 
dead y‟know, which isn‟t the one I want.  I mean the 
transplant worked like a dream. (L692)   
accepting of losses – 
preferable to the 
alternative 
 
 
 
 
 
 
Reappraising and accepting- the losses 
are worth it 
 
 
 
 
 
 
A new perspective 
on life and living 
 
 
Isobel:  the transplant wasn‟t easy.  I‟m not going to 
say I brushed it just under the carpet, because it wasn‟t.  
It was hard going.  But em, [slight pause] I feel – well 
the doctors had said to me, y‟know, I was so ill before 
it and look how I‟ve come on now.  Y‟know?  And just 
look at it like that. (L721)   
worth the hard 
journey for sake of 
improved health    
 
Harold:  Well, I mean, it‟s frustrating and sad but um, I 
can still do enough things and enjoy being with people 
and talking to people and having friends, that em, I‟d 
rather be here than not [laughs].  So, it‟s like that.  
(L199)   
 
losses reappraised 
as being worth it for 
sake of being alive 
Mary:  but I think after a wee while, you‟re 
relationship kind of goes back – with all of them I 
think goes back to what it was like before...it‟s same 
old mum again.  (L376)   
 
family relationships 
and sense of self 
returning to normal 
over time 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changing over time 
 
 
 
 
 
 
 
 
Isobel:  after my transplant and that, when I was 
feeling really ill and down and that – you know, I said 
to my husband, look – I need to write letters and 
that...because I felt, em, I just felt that [slight pause] I 
didn‟t say enough, y‟know, before.  So, y‟know, I‟d 
done all that on paper and that but [tails off].  But now, 
it‟s just – it seems a pinch of salt now [laughs]. (L266) 
   
 
physical and 
emotional wellbeing 
improving over 
time 
David: I‟ve been able to get back to doing some things 
already so y‟know, it‟s eh, I‟m really quite positive 
about it.  (L466)   
physical health 
improving over  
time 
Geoff:  I think we‟re picking up the pieces – we‟re 
doing things together again (L385)   
family life resuming 
over time  
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